Influence of the polyunsaturated fatty acids linoleic acid, arachidonic acid, [alpha]-linolenic acid and [gamma]-linolenic acid on melanogenesis of B16 mouse melanoma cells and normal human melanocytes by Stöckli, Martin
    
 
 
Influence of the polyunsaturated fatty acids 
linoleic acid, arachidonic acid, α-linolenic 
acid and γ-linolenic acid on melanogenesis 
of B16 mouse melanoma cells and normal 
human melanocytes 
 
 
 
 
INAUGURALDISSERTATION 
 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der 
Philosophisch-Naturwissenschaftlichen Fakultät 
der Universität Basel 
 
 
 
von 
Martin Stöckli  
aus Hofstetten (SO) 
 
    
 
 
 
 
 
 
Genehmigt von der Phi losophisch-Naturwissenschaft l ichen Fakultät 
auf Antrag von 
Prof Dr. Jürg Meier und PD Dr. Reto Brun 
 
 
Basel ,  den 12. Februar 2002 
 
 
 
Prof.  Dr. Andreas D. Zuberbühler 
Dekan 
 
 
    
 
 
 
 
 
 
 
 
 
Dedicated to my wife Marlene 
 
 
    
 
 
 Contents  
 1  
Contents 
CONTENTS ................................................................................................... 1 
ABBREVIATIONS.......................................................................................... 4 
SUMMARY .................................................................................................... 6 
1. INTRODUCTION....................................................................................... 7 
1.1 The skin .......................................................................................................................... 7 
1.2 Melanocytes and melanogenesis.................................................................................. 10 
1.2.1 Melanocytes .................................................................................................................. 11 
1.2.2 Melanin biosynthesis ...................................................................................................... 14 
1.2.3 Regulation of melanogenesis .......................................................................................... 16 
1.2.3.1 Enzymes in skin pigmentation................................................................................... 17 
1.2.3.2 Paracrine control ..................................................................................................... 20 
1.2.3.3 Hormonal control..................................................................................................... 21 
1.2.3.4 Transmembrane and intracellular pathways ............................................................... 24 
1.2.3.5 Effect of UV radiation............................................................................................... 26 
1.3 Fatty acids .................................................................................................................... 27 
1.3.1 Nomenclature of fatty acids ............................................................................................ 27 
1.3.2 Biosynthesis of polyunsaturated fatty acids ...................................................................... 28 
1.3.3 PUFA in cutaneous biology ............................................................................................. 28 
1.4 PUFA and melanogenesis ............................................................................................. 30 
1.6 Objectives for the thesis............................................................................................... 31 
2. MATERIAL AND METHODS ..................................................................... 33 
2.1. Cell culture .................................................................................................................. 33 
2.1.1 Isolation and cultivation of normal human melanocytes..................................................... 33 
2.1.2 Elimination of fibroblast contamination ............................................................................ 35 
2.1.3 Characterization of melanocytes...................................................................................... 36 
2.1.4 Cultivation of B16-F1 and B16-F10 mouse melanoma cells ................................................ 38 
2.1.5 Determination of cell number.......................................................................................... 39 
2.2 Test substances ............................................................................................................ 40 
2.3 Determination of cytotoxicity....................................................................................... 40 
2.3.1 Cytotoxicity on normal human melanocytes...................................................................... 41 
2.3.2 Cytotoxicity on B16 mouse melanoma cells ...................................................................... 43 
2.4 Cell culture and assay conditions ................................................................................. 45 
2.4.1 Mouse melanoma cells ................................................................................................... 45 
2.4.1.1 Melanin content and tyrosinase activity...................................................................... 45 
2.4.1.2 Determination of whole melanin................................................................................ 46 
2.4.1.3 Tyrosinase content .................................................................................................. 46 
2.4.1.4 Expression of tyrosinase gene................................................................................... 47 
2.4.2 Normal human melanocytes ........................................................................................... 47 
2.4.2.1 Melanin content....................................................................................................... 47 
2.4.2.2 Tyrosinase activity ................................................................................................... 47 
 Contents  
 2  
2.4.2.3 Tyrosinase content .................................................................................................. 48 
2.4.2.4 Expression of tyrosinase gene................................................................................... 49 
2.5 Determination of melanin content ............................................................................... 49 
2.5.1 Method according to Ando.............................................................................................. 49 
2.5.2 Method according to Nakajima........................................................................................ 50 
2.5.3 Method according to Bathnagar ...................................................................................... 50 
2.6 Determination of tyrosinase activity............................................................................ 51 
2.6.1 Method according to Ando.............................................................................................. 51 
2.6.2 MBTH-method ............................................................................................................... 51 
2.7 Quantitative analysis of tyrosinase content of cell lysates by ELISA........................... 52 
2.7.1 Quantification of mouse tyrosinase.................................................................................. 53 
2.7.1.1 Solutions and buffers ............................................................................................... 53 
2.7.1.2 Determination of optimum of conjugate concentration ................................................ 54 
2.7.1.3 Determination of optimum concentration of control peptide and anti tyrosinase antibody55 
2.7.1.4 Specificity of the ELISA ............................................................................................ 57 
2.7.1.5 ELISA for the quantification of mouse tyrosinase ........................................................ 59 
2.7.2 Quantification of human tyrosinase ................................................................................. 60 
2.7.2.1 Solutions and buffers ............................................................................................... 61 
2.7.2.2 Specificity of the ELISA ............................................................................................ 62 
2.7.2.3 ELISA for the quantification of human tyrosinase........................................................ 62 
2.8 Quantitative analysis of tyrosinase content of cell lysates by Western Blot ............... 62 
2.8.1 SDS-PAGE..................................................................................................................... 62 
2.8.2 Blotting......................................................................................................................... 63 
2.9 Tyrosinase gene expression ......................................................................................... 65 
2.9.1 Isolation of total RNA from cells ...................................................................................... 66 
2.9.2 Synthesis of cDNA ......................................................................................................... 68 
2.9.3 Quantitative real-time TaqMan PCR ............................................................................... 68 
2.10. Influence of PUFA on melanogenesis of MelanoDerm............................................ 71 
3. RESULTS ................................................................................................ 72 
3.1.Cell culture ................................................................................................................... 72 
3.1.1 Normal human melanocytes ........................................................................................... 72 
3.1.2 Mouse melanoma cells ................................................................................................... 74 
3.2 Cytotoxicity of PUFA..................................................................................................... 76 
3.2.1 Cytotoxicity on normal human melanocytes...................................................................... 76 
3.2.2 Cytotoxicity on mouse melanoma cells............................................................................. 77 
3.3 Effects of PUFA on melanogenesis of mouse melanoma cells...................................... 79 
3.3.1 Tyrosinase mRNA content............................................................................................... 79 
3.3.2 Tyrosinase activity ......................................................................................................... 80 
3.3.3 Melanin content............................................................................................................. 82 
3.3.4 Tyrosinase content ........................................................................................................ 86 
3.4 Effects of PUFA on melanogenesis of normal human melanocytes ............................. 89 
3.4.1 Tyrosinase mRNA content............................................................................................... 89 
3.4.2 Tyrosinase activity ......................................................................................................... 90 
3.4.3 Melanin content............................................................................................................. 91 
3.4.4 Tyrosinase content ........................................................................................................ 92 
3.5 Effects of PUFA on pigmentation of MelanoDerm...................................................... 94 
 Contents  
 3  
4. DISCUSSION.......................................................................................... 98 
4.1 B16 mouse melanoma cells .......................................................................................... 98 
4.2 Normal human melanocytes....................................................................................... 104 
4.3 Concluding remarks.................................................................................................... 106 
5. REFERENCES ........................................................................................ 108 
6. ACKNOWLEDGEMENTS ........................................................................ 115 
7. CURRICULUM VITAE ............................................................................ 116 
 
 Abbrevations  
 4  
Abbreviations 
 
AA Arachidonic acid 
ACTH Adrenocort icotrophic hormone 
ASP Agouti  s ignal ing protein 
bFGF Basic f ibroblast growth factor 
cAMP 3’ ,5 ’-cycl ic adenosine monophosphate 
DABCO 1,4-Diazabicyclo[2.2.2]octan 
DHI Dihydroxyindole 
DHICA 5,6-Dihydroxyindole-2-carboxyl ic acid 
DOPA 3,4-Dihydroxyphenylalanine 
ET-x Endothel in x (e. g. ET-1) 
GAPDH Glyceraldehyde-3-phosphate Dehydrogenase 
GTP Guanosine 5’-tr iphosphate 
HGF Hepatocyte growth factor 
IBMX 3-Isobutyl-1-methylxanthine 
ICAM-1 Intercel lu lar adhesion molecule 1 
IL-x Inter leukin x (e. g. IL-1) 
INF-γ  Interferon-γ  
IP3 Inositol 1,4,5-tr isphosphate 
kDa Ki lo Dalton 
LA Linoleic acid 
α-LA α-L inolenic acid 
γ-LA γ-L inolenic acid 
MGF Mast cel l  growth factor 
MHC Major histocompatibi l i ty complex 
MITF Microphtalmia associated transcr ipr ion factor 
MSH Melanocyte st imulat ing hormone 
NHEK Normal human epidermal kerat inocytes 
NHM Normal human melanocytes 
PIP2 Phosphatidyl inosito l  4,5-bisphosphate 
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PKA cAMP dependent protein kinase 
PKC-β  Protein kinase-β  
PLC Phosphol ipase C 
PMA Phorbol-12-myristate-13-acetate 
POMC Pro-opiomelanocort in 
PUFA Polyunsaturated fatty acid 
TNF-α  Tumor necrosis factor-α  
TRP1 Tyrosinase related protein 1 
TRP2 Tyrosinase related protein 2 
WFI Water for inject ion 
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Summary 
 
The inf luence of the polyunsaturated fatty ac ids (PUFA) l inole ic ac id, 
arachidonic ac id,  α- l inolenic ac id and γ- l inolenic ac id on pigmentat ion 
was examined using di f ferent in v i t ro models: monolayer cultures of B16 
mouse melanoma cel ls ,  monolayer cultures of normal human melanocy-
tes and a commercia l ly avai lable reconstructed pigmented epidermis 
that consists of normal,  human-der ived epidermal kerat inocytes (NHEK) 
and melanocytes (NHM) which have been cultured to form a mult i laye-
red, h ighly d i f ferent iated model of the human epidermis that exhib i ts in 
v ivo- l ike morphological  and ul trastructural  character ist ics.  
We used two di f ferent subl ines of B16 or ig in cal led B16-F1 and B16-F10 
for our exper iments.  In both subl ines 25 µM of the PUFA l isted above 
showed two dist inct effects on melanogenesis of the cel ls:  1) the secre-
t ion of intracel lu lar ly produced melanin into the extracel lu lar cul ture 
f lu id was enhanced, and 2) the intracel lu lar melanin content was dec-
reased. The st imulat ion of melanin secret ion was highest after an incu-
bat ion t ime of 24 h, whereas the reduct ion of intracel lu lar melanin was 
most effect ive after 72 h. α-L inolenic ac id and γ- l inolenic ac id decrea-
sed intracel lu lar melanin content more effect ively than arachidonic ac id 
and l inole ic ac id. Futhermore intracel lu lar melanin content of murine 
melanoma cel ls  was reduced more effect ively in B16-F10 subl ine. 
In both subl ines tyros inase act iv i ty was not affected, whereas tyros ina-
se content was reduced. Tyrosinase mRNA level  of B16-F1 cel ls  was 
decreased by l inole ic and arachidonic ac id.  None of the fatty ac ids had 
an inf luence on tyros inase mRNA levels of B16-F10 cel ls .  
None of the polyunsaturated fatty ac ids at a concentrat ion of 100 µM 
affected the melanogenesis of monolayer cul tures of NHM when measu-
r ing the changes in mRNA level ,  content and act iv i ty of tyros inase and 
in the amount of intracel lu lar p igment.  In addit ion the polyunsaturated 
fatty ac ids did not inhib i t  the pigmentat ion of the reconstructed pig-
mented epidermis. 
 Introduction  
 7  
1. Introduction 
 
1.1 The skin 
 
The skin has many functions: i t  not only protects the body against 
mechanical ,  thermic and chemical inf luences, but is a lso a highly 
sensit ive organ for communicat ion. Although the skin has only a 
thickness of a few mi l l imeters, i t  is ,  with a surface of 1.8 m2 and an 
average weight of 4.8 ki lograms, one of the biggest organs of the 
human body. The skin represents an effect ive barr ier and protects 
the remaining organs against mechanical ,  physical ,  chemical and bio-
logical  damage. Furthermore, the skin possesses a crucia l  funct ion in 
heat exchange and protect ion from loss of water. This transepidermal 
water loss is about 0.2 to 0.4 mg/cm2/h at 30°C compared to the rate 
of evaporat ion of water from a free, uncovered water surface that is 
about 35 mg/cm2/h at 30°C. The skin also has important endocr ine 
funct ions such as the synthesis of v i tamin D3, sex hormones and 
pheromones and i t  provides also immunological  defenses.  
 
 
Fig.  1.1  S t ruc ture  o f  the sk in   
The sk in  i s  d iv ided in to  three layers :  the ep idermis  (1) ,  
the dermis  (2)  and the hypodermis  (3) .  The ep idermis  
i s  a  renewing s t ra t i f ied  ep i the l ium.  The dermis ,  that  
cons is ts  of  ex t race l lu la r  matr ix  (co l lagen,  e las t i c  f i -
bers ,  e tc . )  and in terspersed ce l l s  such as  f ib rob las ts ,  i s  
we l l  supp l ied  wi th  b lood vesse ls .  There  are  no d is t inc t  
borders  between the dermis  and the hypodermis  that  
cons is ts  o f  fa t  ce l l s  (ad ipocytes) .  
(From “E lementa dermato log ica” ;  Chr i s tophers  E . ,  
S ter ry  W. ,  Schuber t  Ch. ,  Bräuer  H. ;  Casse l la -R iede l  
Pharma Frankfur t ,  1987)  
 
 Introduction  
 8  
 
The skin is div ided in three layers (Fig.  1.1): the epidermis ar is ing 
from the ectoderm, the dermis and the hypodermis which are of  
mesodermal orig in. 
The epidermis is the outermost part of the skin. It is a cont inual ly 
renewing, laminated, squamous epithel ium (Fig.  1.2).  The main cel ls 
of the epidermis are the so-cal led kerat inocytes. Beside the kerat ino-
cytes there are lymphocytes, Langerhans cel ls,  melanocytes and 
Merkel cel ls interspersed among them. The kerat inocytes are ar-
ranged in layers, which represent the dif ferent stages of their di f fer-
ent iat ion. 
 
 Fig.  1.2  S t ructure  o f  ep idermis  
and under ly ing dermis   
The ep idermis  cons is ts  o f  layers  
o f  kerat inocytes  (a-d)  that  are 
named as  fo l lows:  
s t ra tum basa le  (a) ,  s t ra tum 
sp inosum (b) ,  s t ra tum granu losum 
(c)  and s t ra tum corneum (d) .   
In  the s t ra tum basa le  p igment  
ce l l s ,  the so-ca l led melanocytes ,  
a re  found (1) .   
The dermis  i s  we l l  suppor ted by 
b lood vesse ls  (2)  and cons is ts  o f  
an ext race l lu la r  matr ix  made of  
an amorphous ground substance 
and f ib r i l l a r  s t ructures  such as  
co l lagen bund les  (4) .  The dermis  
i s  a  product  o f  spec ia l i zed ce l l s  
ca l led  f ib rob las ts  (3) .  
(From “E lementa dermato log ica” ;  
Chr i s tophers  E . ,  Sterry  W. ,  Schu-
ber t  Ch. ,  Bräuer H. ;  Casse l la -
R iede l  Pharma Frankfur t ,  1987)  
b
a
d
c
2 
1 
3 
4 
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The layers are named either according to their funct ion or to their 
structure; their names are: 
•  Basal layer or stratum germinat ivum 
•  Spinous layer or stratum spinosum 
•  Granular layer or stratum granulosum 
•  Transit ional layer or stratum lucidum 
•  Horny layer or stratum corneum 
Some of the basal kerat inocytes in the stratum germinat ivum are mi-
tot ical ly act ive and give r ise to cel ls that move up to the more super-
f ic ia l  layers. The stratum germinat ivum is fol lowed by one or more 
layers of larger kerat inocytes which are connected by desmosomes. 
This is the so cal led stratum spinosum. Its name der ives from the 
spine- l ike appearance of the cel ls that result  from shr inking dur ing 
the processing of t issues for histological analyses.  
In the stratum granulosum basophl ic granulae can be seen in the 
l ight microscope, which contain keratohyal in, a precursor of kerat in. 
Above the stratum granulosum there is the stratum lucidum, which 
can be found only in very strongly cornif ied and hair less skin. 
The stratum corneum is made of f lattened epithel ia l  cel ls (corneo-
cytes) arranged in mult ip le layers. These layers are cal led kerat in ized 
layers because of the synthesis of the protein kerat in in those cel ls.  
Kerat in is a structure protein that is specif ic to the skin, hair and 
nai ls.   
This layer of skin is,  for the most part,  dead. Acidic and basic kera-
t ins make up about 80% of the dry mass of the corneocytes. 
It  takes about one month from the t ime a basal cel l  leaves the bot-
tom layer unt i l  i t  is desquamated. 
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The dif ferent iat ion of kerat inocytes includes several steps: 
•  Synthesis and modif icat ion of structural  proteins, especial ly kera-
t ins 
•  Appearance of new organel les, reorganizat ion of exist ing organ-
el les, and loss of organel les 
•  Change in cel l  s ize and shape 
•  Special izat ion of cel lu lar metabol ism 
•  Changes in the propert ies of cel l  membranes 
•  Dehydration 
The stratum corneum is an effect ive barr ier against water loss and is 
most ly impermeable to external substances, such as drugs and toxic 
mater ia ls.  
The dermis consists of extracel lu lar matr ix (col lagen, elast ic f ibers, 
f i lamentous structures and amorphous ground substances made of 
glycosaminoglycans) that is interspersed with f ibroblasts, macro-
phages, mast cel ls and lymphocytes. 
The hypodermis consists of three fatty layers separated by connec-
t ive t issue sheets. The pr imary funct ions of the hypodermis are ther-
moregulat ion, cushioning against mechanical  trauma, contouring the 
body, f i l l ing space, and, the most important, serving as a readi ly 
avai lable source of energy. 
 
 
1.2 Melanocytes and melanogenesis 
 
Although melanocytes comprise only a smal l  proport ion of the cel ls 
present in the epidermis of mammals, they are responsible for the 
product ion of the pigment melanin which accounts for v irtual ly a l l  of 
the vis ib le pigmentat ion in their sk in, hair and eyes. Melanin is pro-
duced in specif ic and unique subcel lu lar organel les,  the so-cal led 
melanosomes. The funct ions of melanin are st i l l  d iscussed. It has a 
c lear role in camouflage and sexual display.  
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But this funct ion is more important for animals than for Homo 
sapiens. It  is thought that in man the main funct ions of melanin are 
protect ion against UV l ight radiat ion and scavenging of radicals.  
 
 
1.2.1 Melanocytes 
 
Melanocytes are highly dendrit ic cel ls that or ig inate from the neural 
crest.  During embryogenesis they migrate through the developing 
body to three pr incipal locat ions: the skin, the eyes and the hair 
bulbs.  
Melanocytes in the eye are distr ibuted in the choroid, i r is and ret ina. 
Eye melanocytes have very low rates of melanogenesis after fetal  de-
velopment and the synthesized pigment is not secreted, but remains 
in the melanocyte. Melanocytes in the eye are thought to funct ion 
essent ia l ly as a photoprotect ive barr ier.  
Melanocytes that migrate to the skin are highly secretory. Within the 
hair bulbs the melanocytes produce melanosomes that are transferred 
to the hair shafts, thus giv ing the hair i ts v is ib le color.  The dif fer-
ences in hair color (and also in skin color) in man are caused by dif-
ferent types of melanin with di f fer ing vis ib le colors that are produced 
by the melanocytes. The types of melanin produced and their dist inct 
funct ional propert ies are discussed later in this chapter. 
With age the melanocytes in the hair bulbs often become dormant 
and stop their melanin product ion, thus leading to the character ist ic 
graying of the hair.  
In skin i tsel f  the melanocytes are located at the junct ion of the der-
mis and the epidermis in the stratum germinat ivum. The melanocytes 
have an extremely low mitot ic rate in contrast to the surrounding 
cel ls.  The melanosomes produced in melanocytes are transferred to 
the neighboring kerat inocytes. The exact mechanism of this transfer 
is st i l l  debated.  
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The associat ion of the melanocyte and i ts surrounding kerat inocytes 
has often been def ined as the „epidermal melanin unit“ where one 
melanocyte is normal ly associated with 36 kerat inocytes.  
As many of the precursors and intermediates in the melanin biosyn-
thet ic pathway are cytotoxic,  the synthesis of the pigment takes 
place in special ized organel les named melanosomes. It  seems that 
melanosomes are special ized members of the lysosomal l ineage of 
organel les [1]. Melanosomes or ig inate from the smooth endoplas-
matic ret iculum as a cytoplasmatic vesic le with an amorphous inter ior 
when analyzed by electron microscopy. At this point the granule is 
cal led a premelanosome and does not contain any of the enzymes 
needed for melanin synthesis.  The main enzyme of melanogenesis, 
the so-cal led tyrosinase, and the other melanogenic determinants are 
synthesized on r ibosomes. They are transported through the rough 
endoplasmatic ret iculum to the Golgi  apparatus where they are post-
translat ional ly processed and glycosylated. They are secreted within 
coated vesic les into the cytoplasmatic mi l ieu and are transported 
specif ical ly to premelanosomes. The enzymes are integrated in the 
melanosomal membrane with their catalyt ic centers facing inward. 
During this process the amorphous structure of the melanosome 
changes into a character ist ic f ibr i lar pattern along the longitudinal 
axis of the melanosome. Studies have shown that tyrosinase is cata-
lyt ical ly competent whi le in transit through the Golgi apparatus. It  is 
not c lear how melanin synthesis is delayed unt i l  the enzyme arr ives 
at the melanosome. It has been proposed that specif ic inhibitors are 
responsible for prevent ing the synthesis of melanin unt i l  incorpora-
t ion within the melanosome. There are four stages in the maturat ion 
of a melanosome: stage I,  the “premelanosome” is a spherical  organ-
el le with matr ix f i laments that are not wel l  def ined; stage II,  in 
which the typical  e l l ipt ical  melanosome is f i l led with a f i lamentous or 
laminar matr ix; stage III is character ized by the deposit ion of e lec-
tron dense mater ia l  on this matr ix; and stage IV, with complete 
opacif icat ion of melanosomal contents by melanin deposit ion [1]. 
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As this process of maturat ion of the melanosome proceeds, the or-
ganel le is steadi ly moving away from the per inuclear region near the 
Golgi  apparatus to the per ipheral dendrit ic areas.  Recent studies 
showed that the act in-based molecular motor Myosin V together with 
the protein Rab27a binds to melanosomes and part ic ipates in their 
transport to dendrites [2]. It  was also shown that k inesin plays an 
important role in melanosome transfer. It  is speculated that Myosin V 
together with Rab 27a is responsible for the transport of melano-
somes in the cel l  cortex, whi le k inesin dr ives the melanosome trans-
fer in the per inuclear region.  
As mature melanosomes arr ive at the end of the melanocyte dendrite, 
they are secreted in areas where the melanocytes intercalate with 
kerat inocytes. The actual transfer of melanosomes into kerat inocytes 
and the kerat inocyte-melanocyte interact ions dur ing the transfer are 
not wel l  character ized. Ear ly l ight and electron microscopy studies 
suggested numerous possible mechanisms for melanosome transfer 
[3]. These include the release of melanosomes into the extracel lu lar 
space fol lowed by endocytosis,  di rect inoculat ion („ inject ion“), 
kerat inocyte-melanocyte membrane fusion and phagocytosis.  Recent 
studies showed that the protease-act ivated receptor-2 (PAR-2) and 
lect ins and their glycoconjugates play an important role in melano-
some transfer [4]. 
Once melanosomes are transferred to kerat inocytes, they are pack-
aged in secondary lysosomes and arranged as supranuclear melanin 
caps above the kerat inocyte nuclei  [5]. As kerat inocytes ascend to 
the epidermal surface from the basal and suprabasal layers where 
melanosome transfer takes place, melanosomes also ascend and are 
retained in the horny- layer cel ls for approximately two weeks. In 
Caucasian skin melanosomes show marked degradat ion and appear as 
melanin dust. In contrast, melanosomes from dark-skinned Negroid 
people show l i t t le degradat ion in the horny-layer cel ls [6]. 
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1.2.2 Melanin biosynthesis 
 
There are basical ly two dist inct forms of melanin in mammals. One 
group is the so-cal led eumelanins that are brown to black and insolu-
ble. The other group is the pheomelanins that are reddish-brown and 
soluble in alkal i .  The in i t ia l  steps in the synthesis of eumelanin and 
pheomelanin are control led by the enzyme tyrosinase, which oxidizes 
the amino acid tyrosine to 3,4-dihydroxyphenylalanine (DOPA) (see 
Fig.  1.3).   
 
 
Fig.  1.3 The b iosynthet i c  pathway of  eumelan in  and pheomelan in .  (From I to  e t  
a l .  [7])  
 
DOPA therefore can spontaneously autooxidize to dopaquinone with-
out tyrosinase, but at s lower rates than in presence of the enzyme. 
Dopaquinone is an extremely react ive compound that, in the absence 
of thio ls in the react ion medium, undergoes intramolecular cycl izat ion 
leading to leukodopachrome and then to dopachrome. Dopachrome 
decarboxylates spontaneously to dihydroxyindole (DHI).  
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In the presence of divalent cat ions and the enzyme DOPAchrome 
tautomerase, also cal led tyrosinase related protein 2 (TRP2), the in-
termediate 5,6-dihydroxyindole-2-carboxyl ic acid (DHICA) wi l l  result.  
DHI is oxidized to indole-5,6-quinone and DHICA is oxidized to In-
dole-5,6-quinone-carboxyl ic acid. It  is speculated that the oxidat ion 
of DHICA is catalyzed by an enzyme cal led DHICA oxidase which is 
synonymous with tyrosinase related protein 1 (TRP1) and the oxida-
t ion of DHI by tyrosinase. The quinones are thought to bui ld melanin 
by oxidative polymerizat ion. Whether this polymerizat ion step is un-
der enzymatic control  is not yet c lear. It  is thought that peroxidase 
or the melanocyte specif ic protein Pmel-17 play a role in this step of 
melanin synthesis [8].  
Melanins generated in v i tro from DHICA are brown in color,  poorly 
soluble and of intermediate weight, whereas those generated from 
DHI are black, total ly insoluble and of high molecular weight. These 
melanins are termed eumelanins. Eumelanins are a mixture of DHI- 
and DHICA melanins and on the indiv idual basis,  the chemistry of 
these pigments may vary to a considerable extent. Thus var ious 
forms of eumelanin that can be found in human skin interact di f fer-
ent ly with UV l ight. 
The other major divers ion in the melanin biosynthesis pathway occurs 
upstream in the pathway immediately fo l lowing the conversion of 
DOPA to dopaquinone. In the presence of sulfhydryl  donors, probably 
cysteine, dopaquinone is converted to cysteinyl-DOPA. 
Further oxidat ion, cycl izat ion and polymerizat ion leads to the forma-
t ion of pheomelanin. Pheomelanins have a yel lowish-red color,  are 
soluble in alkal i  and have a low molecular weight.  
These dif ferent types of melanin are responsible for the dif ferences 
in hair color in mammals and in man. Yel low to br ight red hair result  
from the product ion of pheomelanin, whereas brownish to black hair 
have their or ig in in eumelanin product ion. 
It  is not c lear, how the switch from eumelanin- to pheomelanin pro-
duct ion or v ice versa is control led .   
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For mice i t  is known that the interact ions of melanocyte st imulat ing 
hormone (MSH) and agouti  s ignal ing protein (ASP) play an important 
role [9, 10]. A black phenotype, orig inated by eumelanin product ion 
is e l ic i ted at condit ions under which there is an overst imulat ion of 
the MSH receptor, whereas in contrast,  condit ions under which the 
funct ion of the MSH receptor is abrogated or blocked by ASP result  in 
the product ion of pheomelanin leading to a yel lowish phenotype. To-
day i t  is known that MSH and ASP funct ion s imi lar ly in humans. It 
was shown that the phenotype of red hair and fair  skin unable to tan 
is associated with mutat ions in the gene for the melanocyte-
st imulat ing hormone receptor [11]. 
One can put the quest ion why there exist di f ferent types of melanin. 
Every type of melanin has i ts own physical  and biological  character is-
t ics. DHI melanin is very good in photoabsorpt ion, shows no photo-
toxic i ty, but is highly cytotoxic. DHICA-melanins have reduced pho-
tabsorption, no phototoxic i ty and are less cytotoxic. In contrast ,  
pheomelanin provides only l i t t le photoabsorpt ion, has a high photo-
toxic potent ia l ,  but low cytotoxic i ty.  The optimum type of melanin 
must be a compromise between photoprotect ion whi le minimizing 
cyto- and phototoxic i ty.  
 
 
1.2.3 Regulation of melanogenesis 
 
Mammalian and therefore human pigmentat ion is a very complex 
process. This biosynthetic pathway is regulated at dif ferent levels by 
a var iety of dist inct factors. There are enzymes such as tyrosinase, 
TRP1 and TRP2 that regulate the synthesis of melanin.  
These enzymes are also regulated (their act iv i ty, their product ion at 
the transcr ipt ional and translat ional level ,  etc.).  Kerat inocytes pro-
duce a lot of substances that play an important role in regulat ing 
melanocyte growth and dif ferent iat ion. One of the major factors that 
affect human pigmentat ion is UV radiat ion.  
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One can div ide skin pigmentat ion in two components. The f irst ,  con-
st i tut ive pigmentat ion, is the pigmentat ion which is genet ical ly de-
termined in the absence of st imulatory inf luences, or in other words, 
the level of pigmentat ion in parts of the body that are not normal ly 
exposed to UV radiat ion. The second component, facultat ive pigmen-
tat ion, is the level of pigmentat ion or tanning that occurs in response 
to st imulatory effects that are in man UV radiat ion and, to a certain 
degree, hormones.  
These external st imul i  are converted in intracel lu lar messenger mole-
cules that affect melanogenesis.  Different s ignal ing pathways mediat-
ing melanogenesis wi l l  be discussed later in this chapter.  
 
 
1.2.3.1 Enzymes in skin pigmentation 
 
There are three key enzymes known to date, a l l  physiological ly asso-
ciated with melanosomes: tyrosinase, TRP1 and TRP2 (Tab. 1.1).  Ty-
rosinase, TRP1 and TRP2 are glycoproteins embedded in the melano-
some membrane that share 70-80% nucleot ide sequence homology 
with 30-40% amino acid ident i ty. Among these three enzymes, ty-
rosinase is the most cr i t ical  and rate l imit ing enzyme. 
 
Tyrosinase  
Tyrosinase is the rate- l imit ing enzyme in the melanin biosynthesis 
pathway. It  is a mult i funct ional copper-containing glycoprotein with a 
molecular weight de novo of 65 kDa and about 75 kDa when glycosy-
lated [12]. It  is an unusual enzyme as i t  catalyzes three dist inct 
chemical react ions [13].  
It  catalyzes the f i rst two steps in melanogenesis: the hydroxylat ion of 
tyrosine to DOPA and then the oxidat ion of DOPA to dopaquinone. 
The third catalyt ic act iv i ty is the oxidat ion of DHI to indole-5,6-
quinone. This funct ion of the enzyme is st i l l  debated.  
 Introduction  
 18  
Another cur ios i ty of tyrosinase is the fact that i t  requires DOPA as 
cofactor for the tyrosine hydroxylase react ion [14]. The product is 
therefore the cofactor for the synthesis of the product.  
Rates of tyrosine hydroxylat ion in the absence of the cofactor are 
negl ig ib le. That raises the quest ion where the in i t ia l  DOPA cofactor 
der ives from, s ince DOPA is not a normal amino acid avai lable within 
the cel l .  This important quest ion is st i l l  unresolved.  
Tyrosinase is an extremely stable protein that is highly resistant to 
heat or proteases. It  a lso has an unusual ly long biological  half- l i fe up 
to 10 hours in vivo. 
Tyrosinase can be divided into three domains: an inner domain that 
resides ins ide the melanosome, a transmembrane domain and a cyto-
plasmatic domain. The biggest part of the enzyme resides inside the 
melanosome and only 10% or 30 amino acids const i tute to the cyto-
plasmatic domain [15]. The inner domain contains the whole catalyt ic 
act iv i ty whi le the cytoplasmatic domain seems to play an important 
role in cel lu lar traff ick ing of tyrosinase and in regulat ion of tyrosi-
nase act iv i ty.  
The transcr ipt ion of the tyrosinase gene is regulated by a transcr ip-
t ion factor cal led microphtalmia-associated transcr ipt ion factor 
(MITF) [16]. MITF belongs to the basic-hel ix- loop-hel ix-z ipper fami ly 
and is known to interact with a specif ic DNA sequence termed M-box 
with the sequence GTCATGTGGCT that is present in the promoter re-
gion of the tyrosinase gene [17]. There is evidence that the intracel-
lu lar second messenger cAMP increases tyrosinase gene expression by 
enhancing the interact ion between MITF and the M-box [18]. 
The regulat ion of the act iv i ty of tyrosinase is managed by phosphory-
lat ion of the enzyme by protein k inase C-β  [19].  
The cytoplasmatic domain of tyrosinase contains two ser ine residues 
at amino acid posit ions 505 and 509 that are candidates for phos-
phorylat ion by this ser ine/threonine kinase [15].  
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A recent study showed that PKC-β  phosphorylates both ser ines but i t  
is not c lear whether phosphorylat ion of one or both of the ser ine 
residues is required for the act ivat ion of tyrosinase [20]. 
 
TRP1 
The funct ion of TRP1 is not c lear yet. It  has been proposed to be a 
lower specif ic act iv i ty tyrosinase [21], a dopachrome tautomerase 
[22], a tyrosine hydroxylase [23], a DOPA oxidase [24], a melano-
somal catalase [25], or a DHICA oxidase [8]. More recent ly i t  has 
been suggested that TRP1 inf luences the act iv i ty of tyrosinase by 
stabi l iz ing and/or forming a complex with tyrosinase [26]. In the pro-
tein data base Swiss Prot the catalyt ic funct ion of TRP1 is stated as 
„Oxidat ion of 5,6-dihydroxyindole-2-carboxyl ic acid (DHICA) into In-
dole-5,6-quinone-2-carboxyl ic acid. May regulate or inf luence the 
type of melanin synthesized“. The molecular weight of the precursor 
molecule is about 60 kDa. Synonyms for the enzyme are: DHICA oxi-
dase, catalase B, glycoprotein 75 and melanoma antigen gp75. About 
the regulat ion of the transcr ipt ion of the corresponding gene and the 
act iv i ty of the enzyme nothing is known. 
 
TRP2 
The funct ion of TRP2 is that of a dopachrome tautomerase [27]. The 
molecular weight of the enzyme is disputed. The records range from 
46 to 80 kDa.  
The reason for these discrepancies in molecular weight is the fact 
that i t  is very di f f icult  to pur i fy TRP2 as i t  co-puri f ies with tyrosinase 
and may exist in a complex with tyrosinase, TRP1 and possibly other 
proteins.  
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 T y r o s i n a s e  TRP1  TRP2  
S ynonym  
Mon ophen o l  monooxy -
gena se  
 
DH ICA  o x i d a s e  
Ca t a l a s e  B  
G l y c op r o t e i n - 75  
Me l a noma  an t i g en  gp75
Dopach r ome  t au t ome ra se  
Dopach r ome  de l t a -
i s om e ra se  
 
Spe c i f i c i t y  Me l a no cy t e  Me l a no cy t e  Me l a no cy t e  
Mo l e c u l a r  we i g h t  
6 5  kDa  ( d e  novo )  
7 5  kDa  ( g l y c o s y l a t ed )  
6 0  kDa  ( unp r o ce s sed  
p r e cu r s o r )  
4 6  –  80  kDa   
( i n  d i s pu t e )  
I s oe l e c t r i c  p o i n t  4 . 3  Unknown  Unknown  
Ca t a l y t i c  a c t i v i t y  
T y r o s i n e  ?  DOPA  
DOPA  ?  Dop aqu i none  
DH I  ?  I ndo l q u i none  
DH ICA  ? I ndo l q u i n one  
c a r boxy l i c  a c i d  
Dopa ch r ome  ?  DH ICA  
Ha l f  l i f e  4  –  10  h  ( i n  v i v o )  Unknown  Unknown  
M i s c e l l a neou s  
Hea t - s t a b l e  
P r o t e a se - s t a b l e  
Che l a t o r - s e n s i t i v e  
G l y c o s y l a t ed  
Memb rane - bound  
DOPA  c o f a c t o r -
d ependen t  
G l y c o s y l a t ed  
Memb rane - bound  
Hea t - s en s i t i v e  
P r o t ea se - s e n s i t i v e  
Che l a t o r - i n s en s i t i v e  
G l y c o s y l a t ed  
Memb rane  bound  
DOPA  c o f a c t o r -
i n dependen t  
Table 1.1  Character i s t i cs  o f  melanogen ic  enzymes 
 
 
1.2.3.2 Paracrine control 
 
Kerat inocytes play an important role in the regulat ion of melanocyte 
growth and dif ferent iat ion. They produce a var iety of di f ferent fac-
tors that act on melanocytes.  
Melanocytes do not produce their own growth factors under normal 
condit ions. There exist reports that one of the f i rst steps in mela-
noma development is the synthesis of autocr ine growth factor basic 
f ibroblast growth factor (bFGF) by melanocytes [28]. There is a lso 
evidence that α-MSH acts as an autocr ine factor on melanocytes in 
melanogenesis [29].  
Under normal condit ions the prol i ferat ion of melanocytes is regulated 
by kerat inocytes through the product ion of the main melanocyte 
growth factor bFGF. Other melanocyte growth factors include mast 
cel l  growth factor (MGF) and hepatocyte growth factor (HGF).  
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Their act ions are not specif ic to melanocytes. HGF st imulates the 
growth of a variety of epithel ia l  cel ls,  and mast cel l  growth factor 
(synonymous with stem cel l  factor, steel factor or c-kit  l igand) af-
fects the prol i ferat ion of  numerous cel l  types. 
The most studied of the local ly produced factors that regulate 
melanocytes are the cytokines and other inf lammatory mediators. It  
has been suspected that some of these substances mediate the ef-
fects of UV radiat ion and post- inf lammatory pigmentary responses.  
The cytokines inter leukin 1 (IL-1), IL-6 and tumor necrosis factor-α  
(TNF-α) have been reported to inhibit both melanogenesis and 
melanocyte prol i ferat ion. These cytokines as wel l  as TNF-β ,  IL-7 and 
interferon-γ  (INF-γ) a lso induce the expression of intercel lu lar adhe-
sion molecule-1 (ICAM-1) and MHC class II molecules on cultured 
melanocytes. This could ref lect a change in melanocyte funct ion from 
a melanin producing cel l  to an immune competent cel l .   
Endothel ins play an important role in melanocyte development, 
growth, melanogenesis,  moti l i ty and dendric i ty. Studies showed that 
ET-1 affects melanocyte dendric i ty [30], prol i ferat ion [31], and 
melanogenesis [32], whi le ET-3 plays an important part in regulat ion 
of progenitor number and dif ferent iat ion in melanocyte development 
[33]. To date ET-1 is the only mitogen that increases both melanin 
synthesis and melanocyte prol i ferat ion at very low doses in the 
nanomolar range [32].  
 
 
1.2.3.3 Hormonal control 
 
Melanocytes respond to many hormonal st imul i ,  and the two most im-
portant groups are MSH pept ides and sex steroids. 
 
MSH peptides 
There exist several  MSH pept ides. They are formed together with 
numerous other pept ides including adrenocort icotrophic hormone 
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(ACTH), l ipotrophins and endorphins from a precursor molecule cal led 
pro-opiomelanocort in (POMC) (see Fig.  1.4).   
 
 
Fig.  1.4  The POMC fami ly  o f  pept ides  ( f rom Thody [12])  
The core  sequences  are  shown as  ?  and as  ? .   
ACTH – adrenocor t icot roph ic  hormone,  CLIP –  cor t i cot roph ic  l i ke  in termediate  
lobe pept ide ,  βEP – β -endorph in ,  JP  –  jo in ing pept ide ,  LPH – l ipot roph in,  MSH – 
melanocyte  s t imu la t ing hormone,  POMC – pro-op iomelanocor t in 
 
The main s i te of POMC product ion is the pitu itary gland but there is 
evidence that this protein and i ts c leavage products are also pro-
duced in the skin [34, 35]. The pigmentary act ion of α-MSH in man 
was f i rst demonstrated by Lerner and McGuire [36].  
There exist several reports that α-MSH and related pept ides fai l  to 
have an effect on melanogenesis in cultured human melanocytes 
[37]. There is strong evidence that this unresponsiveness of cultured 
melanocytes to MSH in v i tro is re lated to mitogens normal ly used in 
melanocyte cel l  culture. If  these mitogens are avoided, human 
melanocytes readi ly respond to MSH [38].  
In mice the main effect of MSH is the increase of synthesis of eume-
lanin.  
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From the MSH or melanocort in receptor seven dif ferent subtypes are 
known to date. Melanocytes express melanocort in receptor 1 (MC1R) 
[39].  
The MC1R is a seven pass transmembrane G protein coupled receptor 
which act ivat ion leads to an increase in the second messenger cAMP. 
In man at least 20 al le l ic var iants of the MC1R have been descr ibed 
to date [11]. Four al le les are c lear loss-of-funct ion mutat ions that 
are causal ly associated with the development of red hair and cutane-
ous sensit iv i ty to UV radiat ion (tendency to burn) that is recognized 
as a major r isk factor for melanoma skin cancer.  
Recent studies showed that α-MSH is not the only POMC pept ide with 
melanogenic act iv i ty and i t  is now establ ished that ACTH binds to the 
MC1R and is a lso act ive in this respect [40]. There are reports that 
ACTH pept ides are even more potent than α-MSH in st imulat ing 
melanogenesis and that ACTH1-17 is especial ly potent [29].  
As i t  was said before, the major s i te of α-MSH product ion in mam-
mals is the intermediate lobe of the pituitary. However this lobe is 
vest ig ia l  in adult humans and l i t t le i f  any α-MSH is produced there. 
Now it  is known that the molecule is produced in several  cel l  types in 
the skin including kerat inocytes and melanocytes and therefore the 
act ion that α-MSH has in the skin, is mediated by paracr ine and/or 
autocr ine mechanisms. The same appl ies to ACTH as i t  is produced by 
human kerat inocytes.  
Therefore these pept ides are not hormones in the sense of the def ini-
t ion of a hormone. 
 
Steroids 
Increased pigmentat ion of the nipples, areola, face, abdominal skin 
and genital ia is descr ibed for pregnant women. A study showed that 
sex stero ids (diethylst i lbestrol  and estradiol) lead to a 1.2 to 2.5 fold 
increase of tyrosinase transcr ipts in cultured human melanocytes 
[41].  
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The amount of TRP1 transcr ipts was l ikewise enhanced but TRP2 
transcr ipts were upregulated of about twenty fold over the in it ia l  
transcr ipt level .   
This is a strong evidence that hyperpigmentat ion dur ing pregnancy is 
mediated by a direct induct ion of melanogenesis by sex steroids. 
 
 
1.2.3.4 Transmembrane and intracellular pathways 
 
Several di f ferent s ignal transduct ion pathways operate in pigment 
cel ls,  the best known being the adenylate cyclase/cAMP system that 
is act ivated by POMC der ived pept ides. The intracel lu lar level of cAMP 
can also be upregulated by drugs or chemicals such as cholera toxin 
or isobutylmethyl xanthine (IBMX). It  was shown that the act ion of 
cAMP is mediated by a cAMP-dependent protein k inase (PKA) which is 
a ser ine/threonine kinase. Act ivat ion of the cAMP pathway leads to 
an increase in tyrosinase gene transcr ipt ion by enhancing the interac-
t ion of the specif ic transcr ipt ion factor MITF with a specif ic DNA se-
quence named M-Box that is located in the promoter region of the 
tyrosinase gene. 
The second important pathway in human melanogenesis is the protein 
k inase C (PKC) pathway. In the last years experiments have shown 
that PKC-β  is necessary to act ivate tyrosinase [20].  
Using a pigmented human melanoma cel l  l ine that expresses PKC-β  
and an amelanot ic subclone that has lost the expression of PKC-β  but 
has equal ly abundant tyrosinase protein, i t  was shown that transfec-
t ion of PKC-β  cDNA into amelanot ic subclone cel ls act ivated tyrosi-
nase.  
It  is thought that PCK-β  act ivates tyrosinase by phosphorylat ion of 
the enzyme at the cytoplasmatic ta i l  and also that the inact ive form 
of PKC-β  is act ivated through the intracel lu lar messenger diacylglyc-
erol  (DAG).  
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DAG is produced together with 1,4,5-tr isphosphate (IP3) from the 
precursor molecule phosphat idyl inositol  4,5-bisphosphate (PIP2) that 
is c leaved by phosphol ipase C (PLC). IP3 interacts with IP3-sensit ive 
Ca2+  channels in the endoplasmatic ret iculum, causing release of  
stored Ca2+ that bind to calmodul in and act ivate a calmodul in de-
pendent k inase (CaM kinase).  
PLC can be act ivated by act ivated G proteins or by receptor tyrosine 
kinases that are discussed later in this chapter.  To date i t  is known 
that ET-1 acts through the PLC/PKC pathway. But i t  is speculated, 
that the dif ferent s ignal transduct ion pathways are not isolated but 
that there exists a cross-talk between them. These speculat ions are 
supported by f indings that ET-1 increases not only tyrosinase act iv i ty 
but also the intracel lu lar cAMP level and the tyrosinase gene 
transcr ipt ion. 
The third important pathway is the tyrosine kinase pathway. 
Receptor tyrosine kinases (RTKs) form a large and important c lass of 
cel l -surface receptors whose l igands are soluble or membrane-bound 
pept ide/protein hormones including insul in and growth factors.  In the 
skin, growth factors act not l ike hormones in the def in i t ion of a hor-
mone, they act as paracr ine or autocr ine factors. To date i t  is known 
that the growth factors b-FGF, MGF and HGF bind to tyrosine kinase 
receptors on the surface on human melanocytes [42].  
Binding of the l igands to the receptor causes the RTK to dimerize and 
the protein kinase of each receptor monomer then phosphorylates a 
dist inct set of tyrosine residues in the cytosol ic domain of i ts dimer 
partner. This process is termed autophosphorylat ion.  
A protein cal led Ras that belongs to the GTPase superfamily associ-
ates with the act ivated domain of the RTK. Ras is a kind of an intra-
cel lu lar switch as i t  is in the on posit ion or in i ts act ive form when 
GTP is bound, and in the off  posit ion or in the inact ive form when 
GTP is hydrolyzed to GDP. The act ivated Ras binds to the N-terminal 
domain of a ser ine/threonine kinase cal led Raf. Raf binds to MEK and 
phosphorylates i t .   
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MEK is a protein kinase that has a dual specif ic i ty as i t  phosphory-
lates both tyrosine and ser ine residues. MEK phosphorylates and act i-
vates MAP kinase that is another ser ine/threonine kinase. Act ivated 
MAP kinase translocates to the nucleus and phosphorylates the ter-
nary complex factors, which in i t iates transcr ipt ion of genes such as 
c-fos that is a very important transcr ipt ion factor.  
 
 
1.2.3.5 Effect of UV radiation 
 
In man, sunl ight is the most important physio logical  st imulator of the 
pigmentary system and is responsible for the tanning response. It  is 
the UV spectrum of solar radiat ion that causes the tanning response 
in the skin. UV radiat ion can be div ided into UVC (200-290 nm), UVB 
(290-320 nm) and UVA (320-380 nm). UVC is absorbed in the atmos-
phere and does not reach the Earth’s surface. UVA and UVB have dif-
ferent effects on human pigmentat ion. It  is thought that UVA is re-
sponsible for the immediate tanning that occurs within 24 hours and 
is based on oxidation of pre-exist ing melanin [43] and redistr ibution 
of melanosomes in the melanocyte from a per inuclear posit ion to a 
more per ipheral,  dendrit ic distr ibution [44]. Immediate tanning is not 
very photoprotect ive against subsequent UV injury in contrast to the 
delayed tanning response.  
The delayed tanning response, that begins as the immediate response 
fades out and progresses for at least 3-5 days after UV exposure, can 
be induced by both UVA and UVB, although the UVA induced response 
is of 2-3 orders of magnitude less eff ic ient.  
The delayed tanning response is accompanied by an increase in ty-
rosinase act iv i ty [45]. UVA induced delayed tanning requires oxygen 
at the t ime of i rradiat ion, whereas the UVB response does not. 
It  is thought that UV-induced DNA photodamage and/or i ts repair is 
at least one of the in i t ia l  s ignals in st imulat ion of melanogenesis due 
to UV radiat ion [46].  
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Other s ignals are paracr ine/autocr ine factors that are produced by 
kerat inocytes or melanocytes after UV st imulat ion.  
 
 
1.3 Fatty acids 
 
1.3.1 Nomenclature of fatty acids 
 
Fatty acids are monocarboxyl ic acids with an acycl ic and unbranched 
structure. Their basic formula is CH3[CH2]nCOOH where n can be any 
number from two to twentytwo. The total  number of carbon atoms is 
in most cases even although odd-numbered carbon atoms containing 
fatty acids also exist.  
Fatty acids can be c lassi f ied according to their chain length and also 
according to their double bonds. Fatty acids that contain no double 
bonds are cal led saturated, with one double bond they are named 
monounsaturated and with two or more double bonds polyunsatu-
rated. Depending on the number of double bonds from 2, 3, 4, 5 and 
6 they are named dienoic, tr ienoic, tetraenoic, pentaenoic, and hex-
aneoic.  
The carbon atoms of the fatty acid can be numbered from carboxyl 
group to the terminal methyl group (∆  numbering system) or from the 
methyl group to the carboxyl s ide (W or n numbering system).  
Palmit ic acid, that is a saturated fatty acid, is abbreviated as C16:0. 
Palmitoleic acid that contains one double bond is abbreviated as 
C16:1,∆9  or as C16:1,n-7 depending on the numbering system that is 
used.  
The number after the ∆  or n s ignif ies the posit ion of the double bond 
relat ive to the carboxyl group or to the terminal methyl group, re-
spect ively. 
 
 
 Introduction  
 28  
1.3.2 Biosynthesis of polyunsaturated fatty acids 
 
Mammalian t issues contain four ser ies of PUFA: n-9, n-7, n-6 and n-3 
[47]. Interconversion between these fami l ies is not possible. The 
precursors of two of these groups are the monounsaturated fatty ac-
ids palmitol ie ic and oleic acids, which can be synthesized endoge-
nously from saturated fatty acids. The precursors for the other two 
groups are necessar i ly der ived from dietary sources: l inole ic and l ino-
lenic acid. Al l  of the PUFAs found in mammal ian t issues are synthe-
sized from these four precursors by desaturat ion and elongat ion cata-
lyzed by enzymes cal led desaturases and elongases.  
 
 
1.3.3 PUFA in cutaneous biology 
 
From a ser ies of papers publ ished in 1929 and 1930 i t  was speculated 
that warm-blooded animals are not able to synthesize appreciable 
quant i t ies of certain fatty acids [48, 49]. Rats maintained on a fat-
free diet over a long per iod developed abnormal i t ies such as growth 
retardat ion, severe scaly dermatosis and extensive water loss through 
the skin. These def ic iencies could be reversed alone by the consump-
t ion of l inole ic acid or l inolenic acid and thus these fatty acids were 
heralded as essent ia l  fatty acids.  
Essent ia l  fatty acid def ic iency syndrome was uncommon in human 
adults and the f i rst study in a human subject was done by the bio-
chemist W. R. Brown, who himself  went on a diet extremely low in fat 
for s ix months [50]. This exper iment fai led to develop any cutaneous 
or other v is ib le abnormal i t ies. With the appearance of parenteral  nu-
tr i t ion based on a system of continuous fat-free infusion, pat ients 
developed alopecia (baldness due to hair fa i lure), br i t t le nai ls,  des-
quamating dermatit is,  and increased suscept ibi l i ty to infect ion. 
The polyunsaturated fatty acids serve as cel lu lar membrane phos-
phol ip id components which can inf luence the physicochemical charac-
ter ist ics of the l ip id bi layer.  
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Changes in membrane l ip ids can modify the mobi l i ty and funct ion of a 
var iety of membrane proteins.  
L inoleic acid is the most abundant PUFA in human skin. There is evi-
dence that one funct ional role of l inole ic acid is i ts involvement in 
the maintenance of the epidermal water barr ier [51]. The physical 
structure of this water barr ier is ascr ibed to sheets of stacked bi lay-
ers that f i l l  the extracel lu lar space of the uppermost layer of the epi-
dermis. These l ip id bi layers contain large amounts of l inoleate r ich 
sphingol ip ids. 
The mechanism of the reversion of the symptoms of essent ia l  fatty 
acid def ic iency (which include hyperprol i ferat ion and transepidermal 
water loss) by feeding with l inoleic acid was elucidated in the last 
years at least for the symptom of hyperprol i ferat ion. In the epidermis 
l inole ic acid is metabol ized to 13-hydroxyoctadecadienoic acid (13-
HODE) [52]. Studies showed that 13-HODE was incorporated into epi-
dermal phosphat idyl inositol  4,5-bisphosphate, result ing in the PLC 
catalyzed release of 13-HODE containing diacylglycerol  [53]. It  is 
thought that this molecule could modulate the act iv i ty of epidermal 
PKC and therefore inf luences epidermal hyperprol i ferat ion and dif fer-
ent iat ion. 
The second important PUFA in the skin is arachidonic acid. It  makes 
up to 9% of the total fatty acids in the epidermal phosphol ip ids in 
human epidermis. It  is the major metabol i te of l inoleic acid. Arachi-
donic acid is metabol ized via the cyclooxygenase pathway, predomi-
nant ly to the prostaglandins E2, F2a, and D2, and also via the 15-
l ipoxygenase pathway, predominantly to 15-hydroxyeicosatetraenoic 
acid (15-HETE) [54]. 
Prostaglandins play a central  role in inf lammation. 15-HETE was re-
ported to improve the symptoms of psor ias is vulgar is after intrale-
s ional inject ion [55] and i t  was also reported to inhibit the 5-
l ipoxygenase act iv i ty and the generat ion of leukotr iene B4 in neutro-
phi ls and basophi ls in v i tro [56]. These in v i tro effects suggest an 
ant i- inf lammatory potent ia l .  
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1.4 PUFA and melanogenesis 
 
From the work of Shono [57] at the beginning of the eight ies of the 
last century i t  is wel l  known that fatty acids have an inf luence on the 
act iv i ty of tyrosinase of B16 mouse melanoma cel ls in v i tro. In the 
last ten years this effect was examined in further work. Altogether 
four papers were publ ished about this topic by Ando and his co-
workers. 
It  was shown that the unsaturated fatty acids ole ic acid, l inole ic acid 
and α- l inolenic acid lead to a decrease in melanin content and tyrosi-
nase act iv i ty in cultured mouse melanoma cel ls of the cel l  l ine B16-
F10 [58]. The growth rate of the cel ls was not al tered by the sub-
stances. In the same study i t  was shown that the fatty acids l ighten 
ultraviolet- induced hyperpigmentat ion of the skin of guinea pigs. It 
was thought that this effect was caused by two dist inct processes; 
f i rst the inhibit ion of the product ion of melanin and second the ac-
celerated turnover of the stratum corneum. 
It was also shown that l inole ic acid can act ivate isolated PKC from 
B16 cel ls in v i tro [59].  
L inoleic acid does not alter the tyrosinase mRNA level in B16 cel ls 
[60] and has neither inhibitory inf luence on the act iv i ty of isolated 
tyrosinase. In a recent study a possible mechanism for the regulatory 
effect of polyunsaturated fatty acids on melanogenesis of cultured 
mouse melanoma cel ls was proposed [61]. It  is thought that in the 
presence of polyunsaturated fatty ac ids in the medium the proteolyt ic 
degradation of tyrosinase is enhanced. 
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1.6 Objectives for the thesis 
 
As previously mentioned, the inhibit ing effect of unsaturated fatty 
acids on melanogenesis is a lready wel l  known. It is proven that the 
addit ion of ole ic,  l inoleic or l inolenic acid to the medium of cultures 
of B16 mouse melanoma cel ls leads to a decreased intracel lu lar 
melanin content [58, 61]. In contrast addit ion of saturated fatty ac-
ids to the medium leads to an increase in intracel lu lar melanin con-
tent. In both cases the melanin content correlates with the act iv i ty of 
tyrosinase, the main enzyme of melanin biosynthesis.   
To date the inhibit ing effect of unsaturated fatt acids  on melano-
genesis was shown in an in v i tro mouse melanoma cel l  culture model 
and in v ivo in an animal model (guinea pig). In the animal model i t  
was shown that unsaturated fatty acids can l ighten UV-induced tan-
ning but i t  is not known i f  they have an inf luence on const i tut ive 
pigmentat ion, which is def ined as the pigmentat ion which is genet i-
cal ly determined in the absence of st imulatory inf luences. 
As cel l  culture model B16 mouse melanoma cel ls were used. From this 
cel l  l ine di f ferent subl ines exist.  The American cel l  bank ATCC l ists 3 
subl ines that are named B16-F0, B16-F1 and B16-F10. The European 
cel l  l ine col lect ion ECACC further l ists a cel l  l ine named B16 mela-
noma 4A5. Therefore i t  seems that four subl ines of the B16 l ine exist.  
These subl ines are not wel l  character ized and nothing is known about 
the dif ferences between them, although B16 cel ls are often used in 
studies invest igat ing melanin biosynthesis.  
To date there exist neither in v i tro nor in vivo studies of the inf lu-
ence of fatty acids on melanogenesis of normal human melanocytes. 
In f i rst experiments with B16-F1 mouse melanoma cel ls and l inole ic 
acid we were not able to detect an inhibit ion in tyrosinase act iv i ty. 
Thus in this work the fol lowing quest ions should be answered: 
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What is the funct ion of l inoleic acid, l inolenic acid (synonym α-
l inolenic acid), arachidonic acid and γ- l inolenic acid on melanogenesis 
of B16-F10 cel ls and B16-F1 cel ls?  
 
Is there a dif ference between the two subl ines of the B16 mouse 
melanoma cel l  l ine in the react ion on the incubat ion with polyunsatu-
rated fatty acids ? 
 
Do polyunsaturated fatty acids also affect the melanin synthesis of  
cultured normal human melanocytes? 
 
Which effects have polyunsaturated fatty acids in a pigmented 3D in 
v i tro skin model? 
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2. Material and Methods 
 
2.1. Cell culture 
 
2.1.1 Isolation and cultivation of normal human melanocytes 
 
Normal human melanocytes were isolated from human foreskins and 
cultured according to the method of Eis inger [62] with few modif ica-
t ions. 
 
Culture media and solutions 
 
PBS without Ca2+ and Mg2+ (PBSA) 
 137 mM NaCl [Merck 6404] 8.00 g/ l i ter 
 2.68 mM KCl [Merck 4936] 0.20 g/ l i ter 
 1.47 mM KH2PO4 [Merck 4873] 0.20 g/ l i ter 
 8.09 mM Na2HPO4 * 2H2O [Merck 6580] 1.44 g/ l i ter 
 
PBS-EDTA 
 137 mM NaCl [Merck 6404] 8.00 g/ l i ter 
 2.68 mM KCl [Merck 4936] 0.20 g/ l i ter 
 1.47 mM KH2PO4 [Merck 4873] 0.20 g/ l i ter 
 8.09 mM Na2HPO4 * 2H2O [Merck 6580] 1.44 g/ l i ter 
 0.537 mM EDTA [Sigma ED2SC] 0.20 g/ l i ter 
 
0.25 % Trypsin 
2.5% Trypsin [Gibco25090-028] was di luted with PBSA. 
 
Trypsin-EDTA 
2.5% Trypsin [Gibco25090-028] was di luted with PBS-EDTA to a con-
centrat ion of 0.05%. 
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Complete medium 
 MEM with NEAA [Gibco 41500-067] 
100 units/ml penic i l l in [Gibco 15140-122] 
 0.1 mg/ml streptomycin [Gibco 15140-122] 
 0.25 µg/ml Fungizone  [Gibco 15290-018] 
 
Washing medium 
 MEM with NEAA [Gibco 41500-067] 
 1000 units/ml penic i l l in [Gibco 15140-122] 
 1 mg/ml streptomycin [Gibco 15140-122] 
 2.5 µg/ml Fungizone  [Gibco 15290-018] 
 
Growth medium 
Complete medium without Fungizone  supplemented with: 
 5% FBS [Gibco 10091-148] 
 16 nM PMA [Sigma P 8139] 
 2.5 nM cholera toxin [Sigma C 8052]  
 0.1 mM IBMX [Sigma I 7018] 
 
Method 
 
Human foreskins from circumcis ions were col lected in complete me-
dium and stored near the surgical  area at 4°C. Specimens were del iv-
ered to the cel l  culture laboratory the same day. The skin was trans-
ferred to a laminar f low hood where the fol lowing preparat ions were 
carr ied out under asept ic condit ions. The skin was immersed in wash-
ing medium for 5, 10 and 15 min, each t ime in fresh solut ion. This 
was fol lowed by a wash with complete medium. After that the skin 
was transferred to a Petr i  d ish epidermal s ide down, and using 
curved scissors, fat and connect ive t issue were removed. Then the 
skin was cut into smal l  p ieces of about 25 mm2. The pieces were 
washed with PBSA, placed in 0.25% trypsin and kept at 4°C overnight 
(~16 h).  
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Fol lowing this incubat ion each piece of skin was removed from the 
trypsin solut ion, placed on a Petr i  d ish (dermal s ide down) and held 
with forceps.  
Using a second pair of forceps epidermis was peeled off and col lected 
in trypsin/EDTA solut ion. A s ingle cel l  solut ion was prepared by pi-
pett ing. The solut ion was transferred to a tube containing a smal l  
amount of FBS. The mixture was centr i fuged for 10 min at 180 x g. 
The pel let was resuspended in growth medium, f i l tered through a  
100 µm cel l  strainer [Falcon 2360] and the result ing cel l  suspension 
was seeded into cel l  culture dishes. Cel ls were cultured in a CO2 in-
cubator [Heraeus] at 37°C and 5% CO2. Medium was changed 48 h 
later to remove unattached cel ls.  Afterwards medium was changed 
twice a week and the cel ls were subcultured when conf luence 
reached about 70%. 
 
 
2.1.2 Elimination of fibroblast contamination 
 
Contaminat ing f ibroblasts were el iminated by di f ferent ia l  trypsiniza-
t ion or by select ive destruct ion of f ibroblasts with genit ic in. 
 
a) Differential trypsinization 
 
Medium was discarded and cel ls were washed with PBSA. After that 
0.25% trypsin solut ion was added. The solut ion was removed after i t  
had wet the surface of the cel l  culture dish. The cel ls were observed 
under the inverted microscope [Olympus]. Melanocytes detached 
faster from the surface than f ibroblasts and were col lected in growth 
medium and replated at a density of 1 x 104 cel ls/cm2. If  there were 
st i l l  contaminat ing f ibroblasts, the procedure was repeated. Cel ls 
were cultured at the condit ions descr ibed above and subcultured 
when conf luence was reached. 
 
 Materials and Methods  
 36  
b) Selective elimination with geneticin 
 
If  the method above did not succeed in el iminat ing the f ibroblast 
contaminat ion, the cel ls were select ively k i l led by treatment with ge-
net ic in. This method was descr ibed by Halaban et al .  [63].  
They used genet icin at a dose of 100 µg/ml to select ively k i l l  f ibro-
blasts in mixed cultures of melanocytes and f ibroblasts. We treated 
contaminated cultures with a dose of 200 µg/ml genet ic in for seven 
days as a dose of 100 µg/ml did not succeed in el iminat ing al l  f ibro-
blasts. Melanocytes were not affected by this treatment. 
 
 
2.1.3 Characterization of melanocytes 
 
Melanocytes were identi f ied by immuncytochemistry. Tyrosinase was 
specif ical ly detected with an ant i  tyrosinase ant ibody that was visual-
ized with a second ant ibody labeled with f luorescein. 
 
Materials 
 
•  Cultures of normal human melanocytes 
•  Cultures of normal human f ibroblasts 
•  Culture s l ides [Falcon] 
•  PBSA 
•  Growth medium for melanocytes 
•  Growth medium for f ibroblasts: 
 DMEM [Gibco 31600-026] 
 10% FBS [Gibco 10091-148] 
 100 units/ml penic i l l in [Gibco 15140-122] 
 0.1 mg/ml streptomycin [Gibco 15140-122] 
•  Acetone [Merck] 
•  PBS-Tween:  
PBSA including 0.02% (w/v) Tween 20 [Bio-Rad 170-6531] 
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•  Antibody buffer: 
PBSA including 1% (w/v) BSA [Sigma A-8551] 
•  Antibody I:  
Tyrosinase Ab-1 (T311) [NeoMarkers MS-800-P1] 
•  Antibody II: 
Goat ant i  mouse IgG f luorescein labeled [Pierce 31569] 
•  PolyDABCO: 
 0.3 g Tr is HCl [Sigma T-3253] 
 2.2 g Tr is base [Sigma T-1503] 
 20.0 ml H2O bidest.  
 2.0 g Polyvinyl a lcohol [Sigma P-8136] 
 4.5 ml Glycer in [Merck 4094] 
 0.75 g DABCO [Fluka 33480] 
Tr is HCl and Tr is base were solubi l ized in 20 ml H2O. Polyvinyl  a lco-
hol was added in port ions to the solut ion under st i rr ing. The solut ion 
was st i rred for 30 min. Then glycerin was added and the solut ion was 
warmed unt i l  g lycer in had dissolved and the solut ion became clear. 
Afterwards the solut ion was cooled down to RT and pH was set to 
8.70 with 2 M HCl. The solut ion was stored at 4°C. 
 
Method 
 
The cel ls were cultured in culture s l ides in a humidif ied incubator at 
37°C and 5% CO2 for four days. The medium was discarded, the me-
dia chamber removed and the cel ls were washed with PBSA three 
t imes. After this the cel ls were f ixed for 10 min with ice cold acetone 
on ice. After this f ixat ion the s l ides were washed three t imes with 
PBS-Tween. Ant ibody I was di luted 1:100 with ant ibody buffer and 
100 µ l  of the solut ion were pipetted on the culture s l ide. The culture 
s l ides were incubated for 45 min at RT in a humid chamber. After this 
incubat ion the s l ides were washed with PBS-Tween three t imes. Ant i-
body II was di luted 1:50 with ant ibody buffer.   
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On each s l ide 100 µ l  of ant ibody solut ion were pipetted. The s l ides 
were incubated at RT in the dark in a humid chamber. After 45 min 
the s l ides were washed three t imes with PBSA and mounted with 
PolyDABCO. The specimens were examined under a f luorescence mi-
croscope [Olympus BX50] using an exciter f i l ter BP460-490 [Olympus] 
and a barr ier f i l ter BA515IF [Olympus]. Photographs were taken using 
a ref lex camera [Olympus OM-4 Ti] and 35 mm f i lm [Kodak]. 
 
 
2.1.4 Cultivation of B16-F1 and B16-F10 mouse melanoma cells 
 
B16-F10 (CRL-6475) and B16-F1 (CRL-6323) mouse melanoma cel ls 
were purchased from ATCC. These cel l  l ines were isolated from the 
mouse strain C57BL/6J and deposited at ATCC by the Naval Biosci-
ences Laboratory. The fol lowing cel l  l ine descr ipt ions were given by 
ATCC: 
 
B16-F1 Organism: Mus musculus (mouse) 
 Tissue: melanoma 
 Strain: C57BL/6J 
 Morphology: f ibroblast- l ike 
 Depositors: Naval Biosciences Laboratory 
 Tumorigenic: yes, in syngenic mice 
 Note: This cel l  l ine produces melanin which may  
cause the culture medium to turn 
brown/black. This is normal and should not 
be mis interpreted as contaminat ion 
 
B16-F10 Organism: Mus musculus (mouse) 
 Strain: C57BL/6J 
 Depositors: Naval Biosciences Laboratory 
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The growth medium consisted of: 
 DMEM  [Gibco 31600-026] 
 5%  FBS [Gibco 10091-148] 
 100 units/ml  penic i l l in  [Gibco1 5140-122] 
 0.1 mg/ml streptomycin [Gibco1 5140-122] 
 
The cel ls were grown in cel l  culture Petr i  d ishes in a humidif ied CO2 
incubator at 37°C and 7% CO2. Due to the rapid growth cel ls were 
subcultured twice a week on Monday and on Fr iday. Medium was 
changed on Wednesday. For subcultur ing the medium was discarded, 
the cel ls were washed with PBSA and l i t t le 0.25% trypsin solut ion 
was added. After i t  had wet the surface the solut ion was removed 
and the cel ls were incubated at 37°C for 5 min. After this incubat ion 
the cel ls had detached from the surface and were col lected in culture 
medium. The cel ls were seeded at a density of ~1.7 x 103/cm2. 
 
 
2.1.5 Determination of cell number 
 
The cel l  number was determined using a cel l  counter CASY  1 
[Schärfe System]. For count ing, monolayers had to be trypsinized and 
resuspended in medium. 
 
Material  
 
•  Cel l  monolayer 
•  PBSA 
•  0.25% Trypsin 
•  Growth medium 
•  CASYton [Schärfe System] 
•  Counting cups [Schärfe System] 
•  CASY  1 [Schärfe System] 
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Method 
 
The cel l  suspension was di luted 1:100 in 10 ml CASYton counting 
f lu id in a disposable count ing cup. The suspension was mixed wel l  
and the cel l  number was determined according to the manufacturer ’s 
instruct ions. 
 
 
2.2 Test substances 
 
The fol lowing substances were chosen to invest igate the inf luence on 
melanogenesis of normal human melanocytes and mouse melanoma 
cel ls: 
 
L inoleic acid  (a l l  c i s -9 ,12-Octadecad ieno ic  ac id) [Sigma L-1012] 
Arachidonic acid (a l l  c i s -5 ,8,11,14-E icosatet raeno ic  ac id) [Matreya 1042] 
α-L inolenic acid (a l l  c i s -9 ,12,15-Octadecat r ieno ic  ac id) [Matreya 1024] 
γ-L inolenic acid (a l l  c i s -6 ,9,12-Octadecat r ieno ic  ac id) [Matreya 1153] 
 
The test substances were stored under nitrogen at –20°C to reduce 
oxidat ion of the unsaturated bonds. 
 
Preparation of stock solutions 
 
Stock solut ions (50 mM) [Merck 1.00983] were prepared in ethanol 
and stored under nitrogen at –20°C. 
 
 
2.3 Determination of cytotoxicity 
 
Cytotoxic i ty of the test substances was determined using the neutral  
red uptake (NRU) method [64]. 
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2.3.1 Cytotoxicity on normal human melanocytes 
 
Material  
 
•  Free fatty acid free FBS: 
Free fatty acid free fetal  bovine serum was prepared using three ex-
tract ions with equal volumes of diethyl ether [Merck 1.00921] in a 
separat ing funnel,  according to the method of Ando [58]. The resid-
ual ether was removed using an evaporator [Büchi].  
 
•  Test medium for NHM: 
 MEM with NEAA [Gibco 41500-067] 
 10% free fatty acid free FBS 
 100 units/ml penic i l l in [Gibco 15140-122] 
 0.1 mg/ml streptomycin [Gibco 15140-122] 
 16 nM PMA [Sigma P 8139] 
 0.1 mM IBMX [Sigma I 7018] 
•  NR-medium 
Test medium containing 50 µg/ml neutral  red [Sigma N-4638]. NR-
Medium was prepared 24 hours before use and incubated overnight at 
37°C. Medium was centr i fuged for 10 min at 1000 x g to spin down 
precipitated dye. 
•  NR-f ixat ion solut ion 
1% (v/v) acet ic acid [Merck 1.00063], 50% (v/v) ethanol  
[Merck 1.00983], 49% (v/v) H2O bidest.  The solut ion was stored at 
RT. 
•  Cultures of NHM 
•  96 wel l  cel l  culture plates [Sarstedt] 
•  Deep wel l  p late [Eppendorf] 
•  Mult ipette  p lus [Eppendorf] 
•  Mult ichannel pipette [Eppendorf] 
•  Test substances 
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Method 
 
Cel ls were trypsinized and resuspended in test medium. The cel l  
number was determined using the cel l  counter CASY  1. The cel l  sus-
pension was di luted to 2 x 105 cel ls/ml and using a mult ichannel pi-
pette, 100 µ l  of the cel l  suspension were pipetted into each wel l  of 
column 2 to 12 of a microt i terplate. Into column 1, 100 µ l  of test 
medium were added. This column served as a blank.  
The microt i terplate was incubated in a humidif ied incubator at 5% 
CO2 and 37°C. 
After an incubat ion per iod of 24 h the medium was changed to me-
dium containing var ious concentrat ions of test substance. In a deep 
wel l  p late 1 ml of medium containing the fol lowing concentrat ions of 
test substance was prepared per wel l :   
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 
B 
C 
D 
CO
N
TR
O
L 
50 µM
 LA 
100 µM
 LA 
150 µM
 LA 
200 µM
 LA 
250 µM
 LA 
50 µM
 AA 
100 µM
 AA 
150µM
 AA 
200 µM
 AA 
250 µM
 AA 
E 
F 
G 
H 
BLAN
K 
0.5%
 EtO
H
 
50 µM
 α
-LA 
100 µM
 α
-LA 
150 µM
 α
-LA 
200 µM
 α
-LA 
250µM
 α
-LA 
50 µM
 γ-LA 
100 µM
 γ-LA 
150 µM
 γ-LA 
200 µM
 γ-LA 
250 µM
 γ-LA 
 
The maximal concentrat ion of solvent (ethanol) was 0.5%. The old 
medium was discarded and using a mult ichannel pipette 100 µ l  of the 
medium containing test substance were appl ied to the microt i ter-
plate. The plate was incubated at 37°C and 5% CO2 in a humidif ied 
incubator for 72 h.  
After this incubat ion the medium was discarded and 100 µ l  NR-
medium were pipetted into each wel l  of the microt i terplate and the 
plate was incubated in the incubator for an addit ional hour.  
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Then the medium was discarded, the cel ls were washed with 100 
µ l /wel l  PBSA and 100µ l /wel l  NR-f ixat ion solut ion were added. The 
plate was incubated on a shaker for 15 min and the absorbance at 
540 nm was determined using a microt i terplate reader. 
Blank mean value was subtracted from readings and data were ex-
pressed as percent of untreated control .  Mean values and standard 
deviat ions were calculated. 
 
2.3.2 Cytotoxicity on B16 mouse melanoma cells 
 
Material  
 
•  free fatty acid free FBS: 
Preparat ion see 2.3.1 
•  Test medium for mouse melanoma cel ls 
 DMEM  [Gibco 31600-026] 
 10%  free fatty acid free FBS  
 100 units/ml  penic i l l in  [Gibco1 5140-122] 
 0.1 mg/ml streptomycin [Gibco1 5140-122] 
•  NR-medium 
Preparat ion see 2.3.1 
•  NR-f ixat ion solut ion 
Preparat ion see 2.3.1 
•  Cultures of B16-F1 and B16-F10 mouse melanoma cel ls 
•  96 wel l  cel l  culture plates [Sarstedt] 
•  Deep wel l  p late [Eppendorf] 
•  Mult ipette  p lus [Eppendorf] 
•  Mult ichannel pipette [Eppendorf] 
•  Test substances 
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Method 
 
Cel ls were trypsinized and resuspended in test medium. The cel l  
numbers of the suspensions were determined using the cel l  counter 
CASY  1. The cel l  suspensions were di luted to 2.5 x 104 cel ls/ml and 
using a mult ichannel pipette, 100 µ l  of each cel l  suspension were pi-
petted into each wel l  of column 2 to 12 of a 96 wel l  cel l  culture mi-
crot i terplate. Into column 1, 100 µ l  of test medium were added. This 
column served as a blank. The microt i terplates were incubated in a 
humidif ied incubator at 5% CO2 and 37°C. 
After an incubat ion per iod of 24 h the medium was changed to me-
dium containing var ious concentrat ions of test substance. In a deep 
wel l  p late 1 ml of medium containing the fol lowing concentrat ions of 
test substance was prepared per wel l :   
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 
B 
C 
D 
CO
N
TR
O
L 
31.25 µM
 LA 
62.5 µM
 LA 
125 µM
 LA 
250 µM
 LA 
500 µM
 LA 
31.25 µM
 AA 
62.5 µM
 AA 
125 µM
 AA 
250 µM
 AA 
500 µM
 AA 
E 
F 
G 
H 
BLAN
K 
0.5%
 EtO
H
 
31.25 µM
 α
-LA 
62.5 µM
 α
-LA 
125 µM
 α
-LA 
250 µM
 α
-LA 
500 µM
 α
-LA 
31.25 µM
 γ-LA 
62.5 µM
 γ-LA 
125 µM
 γ-LA 
250 µM
 γ-LA 
500 µM
 γ-LA 
 
The maximal concentrat ion of solvent (ethanol) was 0.5%. The old 
medium was discarded and using a mult ichannel pipette, 100 µ l  of  
the medium containing test substance were appl ied to the microt i ter-
plate. The plate was incubated at 37°C and 5% CO2 in a humidif ied 
incubator for 72 h.  
After this incubat ion the medium was discarded and 100 µ l  NR-
medium were pipetted into each wel l  of the microt i terplate. The 
plates were incubated in the incubator for an addit ional hour.  
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Then the medium was discarded, the cel ls were washed with 100 
µ l /wel l  PBSA and 100 µ l /wel l  NR f ixat ion solut ion were added. The 
plate was incubated on a shaker for 15 min and the absorbance at 
540 nm was determined using a microt i terplate reader. 
Blank mean value was subtracted from readings and data were ex-
pressed as percent untreated control .  Mean values and standard de-
viat ions were calculated. 
 
 
2.4 Cell culture and assay conditions 
 
For the experiments di f ferent approaches were chosen for mouse 
melanoma cel ls and normal human melanocytes. 
 
 
2.4.1 Mouse melanoma cells 
 
2.4.1.1 Melanin content and tyrosinase activity 
 
Cel ls from a running culture were detached from the culture vessel by 
trypsinizat ion and col lected in test medium for mouse melanoma cel ls  
(see 2.3.2). The cel l  number was determined and the fol lowing densi-
t ies were seeded into 175 cm2 f lasks and 100 mm dishes: 
 
4.5 x 105 cel ls/cm2 (24 h incubat ion) 
1.5 x 105 cel ls/cm2 (48 h incubat ion) 
8.5 x 104 cel ls/cm2 (72 h incubat ion) 
 
The volume of medium was 30 ml for the f lasks and 10 ml for the 
dishes.  
The f lasks and dishes were incubated in a humidif ied atmosphere at 
37°C and 5% CO2 for three hours. After this incubat ion per iod almost 
al l  cel ls had sett led to the surface and 0.5 % (v/v) of a 5 mM stock 
solut ion of the test substance in ethanol or of di luent alone were 
added to the medium.  
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The cel ls were further incubated in the CO2 incubator for addit ional 
24, 48 or 72 h. Each substance and each incubat ion t ime was tested 
in tr ip l icate. 
After the incubat ion t ime cel ls were harvested. The cel ls from the 
f lasks were used for determinat ion of melanin content (see 2.5.1) 
whereas the cel ls from the dishes served for the tyrosinase act iv i ty 
assay (see 2.6). 
 
 
2.4.1.2 Determination of whole melanin 
 
The assay condit ions were the same as descr ibed in sect ion 2.4.1.1 
with the except ion that 100 mm dishes were used. Medium volume 
for the dishes was 10 ml. At the end of the incubat ion t imes extracel-
lu lar melanin content was determined according to the method de-
scr ibed in sect ion 2.5.3 and intracel lu lar melanin was quanti f ied as 
descr ibed in sect ion 2.5.1. 
 
 
2.4.1.3 Tyrosinase content 
 
Western Blot 
 
Cel ls were seeded at a density of 8.5 x 104 cel ls/cm2 in 10 ml of test 
medium into 100 mm culture dishes. Three hours later the test sub-
stances were added to the medium as descr ibed in sect ion 2.4.1.1. 
The dishes were cultured in the CO2 incubator for an addit ional 72 h. 
Then the tyrosinase content was determined as descr ibed in sect ion 
2.8. 
 
ELISA 
 
Cel ls were seeded at a density of 2 x 104 cel ls/cm2 in 2.5 ml of test  
medium into 6 wel l  plates. Three hours later the test substances were 
added to the medium as descr ibed in sect ion 2.4.1.1.  
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The plates were cultured in the CO2 incubator for further 72 h. Then 
the tyrosinase content was determined as descr ibed (see 2.7). 
 
2.4.1.4 Expression of tyrosinase gene 
 
Cel ls were seeded at a density of 8.5 x 104 cel ls/cm2 in 10 ml test 
medium into 100 mm culture dishes. 24 h after seeding, the medium 
was replaced by test medium containing the polyunsaturated fatty 
acids (25 µM; 0.5 % ethanol in medium) or an equal volume of di lu-
ent. 24 h later the cel ls were harvested, counted with the cel l  
counter CASY  1 [Schärfe System] and tyrosinase mRNA content was 
determined as descr ibed in sect ion 2.9. 
 
 
2.4.2 Normal human melanocytes 
 
2.4.2.1 Melanin content 
 
Cel ls were seeded at a density of 2.5 x 104 cel ls/cm2 in 2.5 ml of test 
medium into 6 wel l  p lates. The test medium was the same as de-
scr ibed before (see 2.3.1). The cel ls were incubated at 37°C and 5% 
CO2 in a humidif ied atmosphere. 24 h later,  100 µM of test substance 
or di luent (ethanol) a lone were added. The concentrat ion of di luent 
was 0.5% (v/v). The cel ls were incubated for addit ional 72 h. Then 
the cel ls were harvested and the melanin content was determined as 
descr ibed in sect ion 2.5.3. 
 
 
2.4.2.2 Tyrosinase activity 
 
Cel ls were seeded at a density of 2.5 x 104 cel ls/cm2 in 1 ml of test  
medium into 12 wel l  p lates. The test medium was the same as de-
scr ibed before (see 2.3.1.).  The cel ls were incubated at 37°C and 5% 
CO2 in a humidif ied atmosphere. After 24 h, 100 µM of test substance 
or di luent (ethanol) a lone were added. The concentrat ion of di luent 
was 0.5% (v/v).  
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The cel ls were incubated for addit ional 72 h. Then the cel ls were 
harvested and the tyrosinase act iv i ty was determined as descr ibed in 
sect ion 2.6.2. 
 
 
2.4.2.3 Tyrosinase content 
 
Western Blot 
 
Cel ls were seeded at a density of 1 x 104 cel ls/cm2 in  10 ml of 
growth medium (see 2.1.1) into 100 mm dishes. The dishes were in-
cubated at 37°C and 5% CO2 in a humidif ied atmosphere. After 24 h 
the medium was changed and replaced with test medium containing 
100 µM of test substance or di luent alone. The concentrat ion of di lu-
ent was 0.5% (v/v). The dishes were incubated at 37°C and 5% CO2 
in a humidif ied atmosphere for further 72 h. Then the cel ls were har-
vested and the tyrosinase content was determined as descr ibed in 
sect ion 2.8. 
 
ELISA 
 
Cel ls were seeded at a density of 1 x 104 cel ls/cm2 in 30 ml of growth 
medium (see 2.1.1) into T150 f lasks and cultured at 37°C and 5% 
CO2 in a humidif ied atmosphere for two weeks.  
Medium was changed twice a week. After this incubat ion period me-
dium was changed and replaced by test medium containing 100 µM of 
test substance or di luent alone. The concentrat ion of di luent was 
0.5% (v/v). The cel ls were incubated for further 72 h. Then the cel ls  
were harvested and the tyrosinase content was determined as de-
scr ibed in sect ion 2.7.2. 
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2.4.2.4 Expression of tyrosinase gene 
 
Cel ls were seeded at a density of 1 x 104 cel ls/cm2 in 10 ml of growth 
medium (see 2.1.1) into 100 mm dishes. The dishes were incubated 
at 37°C and 5% CO2 in a humidif ied atmosphere. After 24 h the me-
dium was replaced by test medium containing 100 µM of test sub-
stance or di luent alone. The concentrat ion of di luent was 0.5% (v/v). 
The dishes were incubated at 37°C and 5% CO2 in a humidif ied at-
mosphere for further 24 h. Then the cel ls were harvested and the ty-
rosinase mRNA content was determined as descr ibed in sect ion 2.9. 
 
 
2.5 Determination of melanin content 
 
The melanin content of mouse melanoma cel ls was determined using 
a method descr ibed by Ando [58]. For normal human melanocytes a 
method descr ibed by Nakaj ima [65] was used. Extracel lu lar melanin 
was quant i f ied using a method descr ibed by Bathnagar [66]. 
 
 
2.5.1 Method according to Ando 
 
The cel ls were detached from the culture vessel by trypsinizat ion. 
Approximately 107 mouse melanoma cel ls were pel leted by centr i fuga-
t ion at 1000 x g for 5 min. The pel let was washed twice with PBSA. 
After a further centr i fugat ion step the supernatant was decanted and 
the pel let resuspended in 200 µ l  of WFI. By addit ion of 1 ml etha-
nol/ether (1:1) opaque substances, other than melanin, were re-
moved. The mixture was incubated at RT for 15 min and then centr i-
fuged at 3000 x g for 5 min. The pel let was suspended in 1 ml of 1M 
NaOH containing 10% (v/v) DMSO. The mixture was incubated on a 
thermomixer at 80°C and 1000 rpm for 30 min.  
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The absorbance was measured at 450 nm and, using a standard curve 
of synthet ic melanin in 1 M NaOH containing 10% (v/v) DMSO, mela-
nin content of the sample and melanin content per cel l  was calcu-
lated.  
 
 
2.5.2 Method according to Nakajima 
 
In this assay cel ls were blotted on a nitrocel lu lose membrane [1.2 µm 
pore s ize; Sartor ius] using a Bio-Dot microf i l t rat ion apparatus [Bio-
Rad]. The cel ls were detached from the culture vessel by trypsiniza-
t ion and col lected in PBSA containing 1 mg/ml trypsin inhibitor [Invi-
trogen]. The cel l  number was determined using the cel l  counter 
CASY  1 [Schärfe System] and approximately 2 x 105 cel ls were blot-
ted on a membrane and f ixed by air drying. An image was taken from 
the membrane using the Camag Reprostar 3 cabinet [Camag], a digi-
ta l  camera [Hitachi] and the software VideoStore [Camag]. The pic-
ture was transformed into gray scale and the density of cel l  b lots was 
analyzed with Scion Image software [Scion Corporat ion]. Data in each 
experiment were normal ized by the control  value and expressed as 
percentage of the control .  
 
 
2.5.3 Method according to Bathnagar 
 
With this assay the melanin secreted to the medium by mouse mela-
noma cel ls was est imated. 
At the end of the incubat ion with test substances the medium was 
decanted and centr i fuged at 800 x g for 10 min to remove f loat ing 
cel ls.  The absorbance of the centr i fuged medium was measured at 
400 nm. Using a standard curve of synthet ic melanin in medium 
melanin content of the sample and melanin content per cel l  was cal-
culated.  
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2.6 Determination of tyrosinase activity 
 
The tyrosinase act iv i ty was determined using the method descr ibed 
by Ando [58] and a second one descr ibed by Winder and Harries [67]. 
The method of Ando was used only for B16 mouse melanoma cel ls 
whereas with the assay of Winder and Harr is (MBTH-method) the ty-
rosinase act iv i ty of NHM and mouse melanoma cel ls was determined. 
 
 
2.6.1 Method according to Ando 
 
After treatment with test substances the cel ls were detached from 
the surface of the t issue culture vessel by trypsinizat ion. The cel ls  
were resuspended in 10 ml PBSA containing 5% FBS and the cel l  
number was determined using the cel l  counter CASY  1. About 2.5 x 
106 cel ls were pel leted by centr i fugat ion at 1000 x g for 5 min. The 
pel let was washed twice with 1 ml of PBSA. Then the cel ls were lysed 
on ice for 15 min in 1 ml of 0.5% sodium deoxycholate [Sigma] in 
WFI. The cel l  extract was c leared by centr i fugat ion at 5000 x g for 10 
min. In a cuvette 250 µ l  of the c leared cel l  extract was mixed with 
750 µ l  of 0.1% L-DOPA in 0.1M phosphate buffer (pH 6.8). The in-
crease of absorbance at 475 nm over a per iod of 10 min at 37°C was 
measured using a spectrophotometer [Pharmacia] and a heat insert.  
 
 
2.6.2 MBTH-method 
 
The or ig inal assay descr ibed by Winder and Harr is was modif ied with 
the purpose to measure the tyrosinase act iv i ty in a microt i terplate 
format. About 3.0 x 105 cel ls were pel leted by centr i fugat ion at 1000 
x g for 5 min. The pel let was washed twice with 1 ml of PBSA and 
lysed in 500 µ l  of lys is buffer for 30 min at 8°C and 750 rpm on a 
shaker. Lysis buffer consisted of 1% (v/v) Tr i ton X-100 [Sigma] in 
PBSA. The cel l  extract was c leared by centr i fugat ion at 10'000 x g for 
5 min.  
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In a microt i terplate the fol lowing volumes were pipetted per wel l :  
 95 µ l  MBTH-buffer (100 mM sodium phosphate pH 7.1, 4%  
by vol.  N,N-dimethylformamide) 
 80 µ l  cel l  extract 
 50 µ l   MBTH solut ion (20.7 mM MBTH in WFI) 
 25 µ l   L-DOPA solut ion (5 mM L-DOPA in PBSA) 
Samples were measured in tr ip l icate. The increase of absorbance at 
492 nm at RT over a per iod of 20 min was measured using a micro-
t i terplate reader [Titertek]. 
 
 
2.7 Quantitative analysis of tyrosinase content of cell lysates by ELISA 
 
The tyrosinase content of crude cel l  extracts of B16 mouse melanoma 
cel ls and NHM was determined using an ELISA. As there exists no 
commercial ly avai lable test k i t ,  an assay was developed according the 
method descr ibed by Crowther [68]. 
 
Assay principle 
 
The assay is a competit ive indirect assay. Competit ion assays are de-
f ined as assays where the detect ing ant ibodies are added with the 
sample s imultaneously. The f i rst step in this pr inciple is to coat the 
surface with the ant igen. In our case this is the control  pept ide. This 
pept ide is used as there is no human or mouse tyrosinase commer-
cia l ly avai lable. Unbound ant igen is washed away. Whi le coat ing the 
plate with ant igen, samples or a di lut ion range of ant igen (control  
pept ide) are incubated with a f ixed amount of ant ibody (anti-
tyrosinase) in a separate microt i terplate. These solut ions are trans-
ferred to the coated plate, where ant ibodies that are not blocked by 
ant igen bind to the ant igen adsorbed on the plast ic surface. Unbound 
ant ibodies are washed away. Bound ant ibodies are detected with an 
enzyme labeled ant i-species ant ibody that binds specif ical ly to the 
f i rst ant ibody.  
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Unbound ant i-species ant ibody is washed away and bound ant i-
species ant ibody is detected and quant i f ied by addit ion of a specif ic 
substrate for the enzyme.  
 
 
2.7.1 Quantification of mouse tyrosinase 
 
2.7.1.1 Solutions and buffers 
 
•  Goat ant i-tyrosinase ant ibody (mouse) 
•  Goat ant i-tyrosinase IgG [RDI RDI-RTTYROSINabG] 
200 µg in 0.5 ml PBS with 100 µg BSA and 0.1% NaN3. Store at 4°C. 
•  Control  pept ide for goat ant i-tyrosinase ant ibody (mouse) 
This peptide is about 20 amino acids in s ize and corresponds to the 
C-terminus of mouse tyrosinase. The pept ide was used to generate 
the antibody descr ibed above. 
100 µg in 0.5 ml PBS with 100 µg BSA and 0.1% NaN3. Store at 4°C. 
•  Rabbit ant i-goat IgG labeled with alkal ine phosphatase 
Rabbit ant i-goat IgG AP labeled [Pierce 31300] 
0.6 mg/ml in 0.01 M Tris HCl,  0.25 M NaCl, pH 8.0, 0.05% NaN3, 15 
mg/ml BSA. Store at 4°C. 
•  Goat IgG 
Goat IgG puri f ied technical  grade [Sigma I 9140] 
•  Tris buffered sal ine (TBS) 
TBS 10 x concentrated [Bio-Rad 170-6435] was di luted with WFI 
[Pentapharm]. The buffer was stored at 4°C. 
•  Wash buffer/Blocking solut ion 
 TBS [Bio-Rad 170-6435] 
 1% (w/v) BSA [Sigma A-8551] 
 0.05% (v/v) Tween 20 [Bio-Rad 170-6531] 
The solut ion was stored at 4°C. 
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•  Carbonate/Bicarbonate buffer 
 13 ml 0.2M Na2CO3*10H2O [Merck 6384] 
 37 ml 0.2M NaHCO3 [Merck 1.06329] 
mix and di lute with WFI to 200 ml. Store at 4°C. 
•  Diethanolamine buffer 
 10 % (w/v) Diethanolamine [Sigma D-0681] 
0.5mM MgCl2*6H2O [Merck 5833] 
set pH at 9.8 with 5 M HCl. Store buffer at 4°C. 
•  Color solut ion 
1 mg/ml p-Nitrophenylphosphat [Sigma 104-105] was solubi l ized in 
diethanolamine buffer.  The solut ion was always prepared fresh before 
use. 
 
 
2.7.1.2 Determination of optimum of conjugate concentration 
 
Optimal concentrat ion of conjugate was determined using chessboard 
t i trat ion method.  
 
Material  
 
•  Nunc-Immuno p late [Nunc] 
•  Rabbit ant i  Goat IgG with AP 
•  Goat IgG solut ion 
•  Carbonate/bicarbonate buffer 
•  Wash buffer 
•  Color solut ion  
•  Mult ichannel pipettes [Eppendorf] 
 
Method 
 
Using the mult ichannel pipette, 50 µ l  of carbonate/bicarbonate buffer 
were pipetted to each wel l  of a Nunc-Immuno p late.  
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The antigen (Goat IgG solut ion) was di luted to 10 µg/ml in carbon-
ate/bicarbonate buffer and 50 µ l  of the di luted ant igen solut ion were 
pipetted into each wel l  of column 1. With the mult ichannel pipette 
the solut ion was mixed and 50 µ l  were transferred to column 2, 
mixed and 50 µ l  t ransferred to column 3, and so on, to column 11. 
No ant igen was pipetted to column 12. The plate was sealed with a 
foi l  [Sarstedt] and then incubated on a shaker at RT for 2 h.  
Then the solut ion was discarded and the wel ls were washed four 
t imes with 100 µ l  of wash buffer.  To each wel l  of the microt i terplate 
50 µ l  of wash buffer were added. The conjugate (Rabbit ant i  goat la-
beled with AP) was di luted 1:1000 with wash buffer and 50 µ l  of this 
solut ion were pipetted into row A. The solut ion was mixed and 50 µ l  
were transferred to row B, mixed, 50 µ l  t ransferred to row C, and so 
on, to row H. The plate was sealed with a foi l  and incubated on a 
shaker at RT for 1 h.  
Then the solut ion was discarded, the plate washed as descr ibed 
above and to each wel l  100 µ l  of color solut ion were pipetted. The 
plate was incubated at RT for 15 min. The absorbance was measured 
at 405 nm with a microplate reader [Titertek]. The data were trans-
ferred to EXCEL and Titrat ion curves were created for each row with 
ant igen di lut ion on x-axis and optical  density on y-axis.  
 
 
2.7.1.3 Determination of optimum concentration of control peptide and anti tyrosinase 
antibody 
 
Opt imal concentrat ions of the control  pept ide and ant i  tyrosinase an-
t ibody were determined using chessboard t i trat ion method.  
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Material  
 
•  Nunc-Immuno p late [Nunc] 
•  Goat ant i-tyrosinase ant ibody 
•  Control  pept ide for goat ant i-tyrosinase ant ibody 
•  Rabbit ant i  Goat IgG with AP 
•  Carbonate/bicarbonate buffer 
•  Wash buffer 
•  Color solut ion 
•  Mult ichannel pipettes 
 
Method 
 
The procedure was the same as descr ibed before (2.4.1.2). In a f i rst 
step the control  pept ide at a concentrat ion of 20 µg/ml was di luted 
from column 1 to column 11. The plate was incubated at RT on a 
shaker for 2 h. Then the plate was washed four t imes and the ant i  
tyrosinase ant ibody at a concentrat ion of 20 µg/ml was di luted in 
wash buffer from row A to row H. The plate was incubated on a 
shaker for 1 h at RT. The plate was washed four t imes and then 50 µ l  
of conjugate, di luted 1:8000 in wash buffer, were added to each wel l .  
An incubat ion step on a shaker at RT for 1 h fol lowed. After this in-
cubat ion the plate was washed four t imes and 100 µ l  of color solut ion 
were added to each wel l .  After a color development for 15 min the 
absorbance was measured at 405 nm. Data were transferred to EXCEL 
and Titrat ion curves were created for each row and each column with 
di lut ion of control  pept ide, resp. ant i  tyrosinase ant ibody, on x-axis 
and optical  density on y-axis.  
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2.7.1.4 Specificity of the ELISA 
 
To check the specif ic i ty of the ELISA, crude cel l  extracts of four cel l  
l ines were analyzed with the assay. Two cel l  l ines were of mouse 
melanoma or igin, one was a human kerat inocyte cel l  l ine and one a 
mouse f ibroblast cel l  l ine.  
 
Cell  culture and preparation of cel l  extracts 
 
Material  
 
•  Cultures of B16-F1 and B16-F10 mouse melanoma cel ls 
•  Cultures of HaCaT human kerat inocyte cel l  l ine 
•  Cultures of 3T3 mouse f ibroblast cel l  l ine 
•  Culture dishes 
•  Incubator 
•  PBSA 
•  TBS 
•  Culture medium consisted of DMEM and 5% FBS and ant ib iot ics for al l  
four cel l  l ines 
•  Lysis buffer 
1% Triton X-100 [Sigma T-8787] in WFI with protease inhibitor cock-
tai l  [Roche 1836170] 
 
The cel ls were cultured in ∅  100 mm culture dishes at 37°C and 7% 
CO2. At conf luence the cel ls were trypsinized and the cel l  number was 
determined with the cel l  counter CASY  1. The cel ls were pel leted by 
centr i fugat ion at 200 x g for 5 min. After washing the pel lets twice 
with TBS, they were solubi l ized in 100 µ l /1.5 x 106 cel ls of lysis 
buffer.  The suspensions were incubated on a shaker at 4°C at 1000 
rpm for 30 min. Then the cel l  extracts were c leared by centr i fugat ion 
at 2000 rpm at 4°C for 10 min.  
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The supernatants were transferred into new tubes and centr i fuged at 
13'000 rpm at 4°C for 30 min. From the supernatants protein and ty-
rosinase contents were determined. 
 
Determination of tyrosinase content by ELISA 
 
Material  
 
•  Nunc-Immuno p late [Nunc] 
•  Microt i terplate [Sarstedt] 
•  Goat ant i-tyrosinase ant ibody 
•  Control  pept ide for goat ant i-tyrosinase ant ibody 
•  Rabbit ant i  goat IgG with AP 
•  Carbonate/bicarbonate buffer 
•  Wash buffer 
•  Color solut ion 
•  Mult ichannel pipettes 
 
Method 
 
To a Nunc-Immuno p late 50 µ l  of ant igen (control  pept ide) at a 
concentrat ion of 0.5 µg/ml in carbonate/bicarbonat buffer were ap-
pl ied. The binding of the ant igen to the wel ls was performed at RT 
for 2 h under shaking. At the same t ime, 50 µ l  of known amounts of 
ant igen as standard, or unknown amounts in samples, were incubated 
with 50 µ l  of 1:200 di luted goat ant i-tyrosinase ant ibody in a micro-
t i terplate at RT for 2 h under shaking.  
After this incubat ion the solut ion from the Nunc-Immuno p late was 
discarded and the wel ls were washed four t imes with 100 µ l  TBS. The 
preincubated mixture of ant igen and ant ibody was transferred to the 
coated plate and incubated at RT under shaking for 1 h.  
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Then the plate was washed four t imes with TBS and 50 µ l  of rabbit  
ant i-goat ant ibody labeled with AP (1:4000 in wash buffer) were 
given to each wel l .  After an incubat ion step at RT for 1 h under shak-
ing, the plate was washed four t imes and 100 µ l  of color solut ion 
were pipetted into each wel l .  The color development was measured 
after 15 min at 405 nm with a microt i terplate reader.  
Data were transferred to EXCEL and a standard curve was created. 
With the help of th is standard curve the tyrosinase concentrat ions of 
the samples were calculated. 
 
 
2.7.1.5 ELISA for the quantification of mouse tyrosinase 
 
Material  
 
•  Samples  
•  Nunc-Immuno p late [Nunc] 
•  Microt i terplate [Sarstedt] 
•  Goat ant i-tyrosinase ant ibody 
•  Control  pept ide for goat ant i-tyrosinase ant ibody 
•  Rabbit ant i  goat IgG with AP 
•  Carbonate/bicarbonate buffer 
•  Wash buffer 
•  Color solut ion 
•  Mult ichannel pipettes 
 
Method 
 
Control  pept ide was di luted with carbonate/bicarbonate buffer to a 
concentrat ion of 0.5 µg/ml and 50 µ l  of this solut ion were appl ied to 
a Nunc-Immuno p late. The plate was sealed with foi l  and incubated 
at RT under shaking for 2 h. 
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At the same t ime the samples and the standards were incubated with 
a known amount of goat ant i-tyrosinase ant ibody in a microt i terplate. 
For this purpose 60 µ l  of wash buffer were given to each wel l  of the 
microt i terplate. An addit ional 30 µ l  of wash buffer were given to the 
wel ls 3 to 12 in row A and E. 
To wel l  A1 and B1 60 µ l  of control pept ide at a concentrat ion of 0.63 
µg/ml in wash buffer were pipetted. Into the wel ls containing 90 µ l  of 
wash buffer (A3 to 12 and E3 to 12) 30 µ l  of sample were given. With 
a mult ichannel pipette a ser ia l  d i lut ion with factor 2 was made from 
row A to D and from E to H for the samples and a ser ia l  d i lut ion with 
factor 2 from row A to H for the standards. The plate was sealed with 
foi l  and incubated at RT for 2 h under shaking.  
Then the solut ion from the Nunc-Immuno p late was discarded, the 
wel ls were washed four t imes with 100 µ l  of TBS and 100 µ l  of the 
preincubated samples and standards were transferred to the corre-
sponding wel ls of the coated plate. An incubat ion step of 1 h at RT 
under shaking fol lowed. After this incubat ion the plate was washed 
four t imes and 100 µ l  of conjugate at a di lut ion of 1:4000 in wash 
buffer were given to each wel l .  After incubat ion at RT for 1 h under 
shaking the plate was washed four t imes and 100 µ l  of color solut ion 
were added to each wel l .  After a color development of 15 min the ab-
sorbance at 405 nm was measured with a microt i terplate reader. Data 
were transferred to EXCEL and a standard curve was created. Using 
this standard curve the concentrat ions of the samples were calcu-
lated. Tyrosinase content was expressed as nanogramm tyrosinase 
per mi l l igramm protein. 
 
 
2.7.2 Quantification of human tyrosinase 
 
For the quant i f icat ion of human tyrosinase no special  exper iments 
were done for determinat ion of opt imum concentrat ions of reagents.  
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The assay design and the concentrat ions were the same as for mouse 
tyrosinase. The only except ion was the s l ight modif icat ion of the con-
centrat ions for the standard curve. 
 
 
2.7.2.1 Solutions and buffers 
 
•  Goat ant i-tyrosinase ant ibody (human) 
Goat ant i-tyrosinase IgG [RDI-TYROSINabG] 
200 µg in 1 ml PBS with 0.2% gelat in and 0.1% NaN3. Store at 4°C 
•  Control  pept ide for goat ant i-tyrosinase ant ibody (human) 
This peptide is about 20 amino acids in s ize and corresponds to the 
C-terminus of human tyrosinase. The peptide was used to generate 
the antibody descr ibed above. 
100 µg in 0.5 ml PBS with 100 µg BSA and 0.1% NaN3. Store at 4°c 
•  Rabbit ant i-goat IgG labeled with alkal ine phosphatase 
(see 2.7.1.1) 
•  Tris buffered sal ine (TBS) 
(see 2.7.1.1) 
•  Wash buffer/Blocking solut ion 
(s. 2.7.1.1) 
•  Carbonate/bicarbonate buffer 
(s. 2.7.1.1) 
•  Diethanolamine buffer 
(s. 2.7.1.1) 
•  Color solut ion 
(s. 2.7.1.1) 
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2.7.2.2 Specificity of the ELISA 
 
The specif i ty of the ELISA was checked by analyzing cel l  extracts 
from NHM and 3T3 mouse f ibroblasts with this assay.  
The experiment was done as descr ibed in sect ion 2.7.1.4. 
 
 
2.7.2.3 ELISA for the quantification of human tyrosinase 
 
Assay was done as descr ibed before (2.7.1.5). 
 
 
2.8 Quantitative analysis of tyrosinase content of cell lysates by Western Blot 
 
The Western Blot method was used as a second method to determine 
the content of tyrosinase of B16 mouse melanoma cel ls and NHM. To 
do this,  cel ls were solubi l ized and the cel l  extracts were c leared by 
centr i fugat ion. The mixture of proteins in these extracts was sepa-
rated by SDS-PAGE and the proteins were blotted on PVDF mem-
branes. Tyrosinase and GAPDH were specif ical ly detected with ant i-
bodies. GAPDH served as a loading control .  
 
 
2.8.1 SDS-PAGE 
 
Material  
 
•  Cel l  lys is 
Cel l  lys is was performed as descr ibed before (2.7.1.4) using the fol-
lowing lys is buffer: 
1% Nonidet P40 [Sigma N-3516], 0.01% SDS [Merck 1.13760] in  
0.1 M Tr is HCl (pH 7.2) with protease inhibitor cocktai l  [Roche 
1836170] 
•  Running buffer 
Tr is/Glycine/SDS buffer [BioRad 161-0732] 
25 mM Tris,  192 mM Glycine, 0.1% (w/v) SDS, pH 8.3 
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•  Sample buffer 
Laemmli sample buffer [BioRad 161-0737] with 5% (v/v) β-
Mercaptoethanol [Sigma M-7522] 
•  Gel 
4-15% Tris-HCl Ready Gel [BioRad 161-1122] 
•  Marker 
Precis ion Protein Standards [BioRad 161-0372] 
•  Mini-Protean II e lectrophoresis cel l  [BioRad 165-2940] 
•  PowerPac 300 [BioRad 165-5051] 
•  Thermomixer Comfort [Eppendorf] 
•  Centr i fuge 5410 [Eppendorf] 
 
Method 
 
Samples were mixed with the same amount of sample buffer and in-
cubated at 99°C for 5 min. After this denaturat ion the samples were 
cooled down to RT and centr ifuged for 2 min at 500 x g.  
The electrophoresis chamber was prepared according to the manufac-
turer ’s instruct ions.  
10 µg of sample and 10 µ l  of marker were separated at 200 V, 
V=const. and 60 mA per gel for 45 min. 
 
 
2.8.2 Blotting 
 
Material  
 
•  Fi l ter paper [BioRad 170-3966] 
•  PVDF Membrane (0.2 µm) [BioRad 162-0174] 
•  Transfer buffer 
Tr is/Glycine buffer [BioRad 161-074] 
25 mM Tris,  192 mM Glycine, 20% (v/v) Methanol [Merck], pH 8.3 
 Materials and Methods  
 64  
•  Tris buffered sal ine (TBS) [BioRad 170-6435] 
20 mM Tris,  500 mM sodium chlor ide, pH 7.5 
•  TBS with Tween (TTBS) 
20 mM Tris,  500 mM sodium chlor ide, 0.05% Tween-20, pH 7.5 
•  Blocking buffer 
TBS with non fat dry mi lk [BioRad 170-6404] 
20 mM Tris,  500 mM sodium chlor ide, 5% (w/v) non fat dry mi lk,  pH 
7.5 
•  Antibody 
Goat ant i-tyrosinase (mouse) IgG [RDI RDI-RTTYROSINabG] 
200 µg in 0.5 ml PBS with 100 µg BSA and 0.1% NaN3. Store at 4°C 
Goat ant i-tyrosinase (human) IgG [RDI RDI-TYROSINabG] 
200 µg in 0.5 ml PBS with 100 µg BSA and 0.1% NaN3. Store at 4°C 
Mouse ant i-GAPDH (rabbit) IgG [RDI RDI-TRK5G4-6C5] 
4.16 mg/ml in PBS with 0.1% NaN3, pH 7.4 
Goat ant i-mouse IgG AP-Conjugate [BioRad 170-6520] 
Rabbit ant i-goat IgG AP-Conjugate [Pierce 31300] 
•  AP color development solut ion 
AP conjugate substrate kit  [BioRad 170-6432] 
The solut ion was prepared freshly before use according to the manu-
facturer ’s instruct ions. 
 
Method 
 
During protein electrophoresis the PVDF membrane and the f i l ter pa-
per sheets were equi l ibrated in transfer buffer at 4°C for 45 min. 
After the cel l  lysates were separated by SDS-PAGE the gel was equi l i -
brated in transfer buffer for 15 min.  
The proteins from the gel were blotted on the membrane according to 
the manufacturer ’s instruct ions, using the semidry blott ing apparatus.  
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The blott ing condit ions were 10 V, V=const. ,  220 mA for 45 min. 
Then the gel was separated from the membrane, r insed with TBS and 
stained with GelCode Blue reagent [Pierce 24590] to check the trans-
fer.  
The membrane was r insed with TBS and blocked in blocking buffer for 
30 min. Then i t  was r insed with TTBS and incubated in ant ibody 
buffer containing goat ant i  tyrosinase antibody di luted 1:200 and 
mouse ant i  rabbit GAPDH ant ibody di luted 1:4200. After an incuba-
t ion of 1 h at RT, the membrane was r insed with TTBS and incubated 
with rabbit ant i  goat ant ibody labeled with AP di luted 1:3000 in ant i-
body buffer for 30 min. After washing the membrane with TTBS, i t  
was incubated for 30 min with goat ant i  mouse IgG labeled with AP 
di luted 1:3000 in ant ibody buffer.   
The membrane was washed with TTBS and TBS and placed in AP color 
development solut ion. After 15 min bands appeared and color devel-
opment was stopped by r ins ing the membrane with tap water.  
The membrane was dr ied, photographed and the bands were densi-
tometr ical ly analyzed using the software Scion Image for Windows 
Beta 4.0.2 [Scion Corporat ion]. 
 
 
2.9 Tyrosinase gene expression 
 
Tyrosinase gene expression was determined by quanti f icat ion of ty-
rosinase mRNA levels.  The tyrosinase mRNA levels were measured by 
quant itat ive real-t ime TaqMan  PCR.  
The TaqMan  RT-PCR method uses the endogenous 5‘  nuclease act iv-
i ty of Ampl iTaq Gold  DNA polymerase to digest an internal ol igonu-
cleot ide probe labeled with both a f luorescent reporter dye and a 
quencher [69]. Assay results are detected by measuring changes in 
f luorescence that occur dur ing the ampl i f icat ion cycle. The f luoro-
genic probe is digested, uncoupl ing the dye and quencher labels and 
causing an increase in the f luorescence s ignal that is proport ional to 
the ampl i f icat ion of target DNA. 
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2.9.1 Isolation of total RNA from cells 
 
Total RNA was isolated using the „High Pure RNA Isolat ion Kit“ 
[Roche 1 828 665] fol lowing the manufacturer ‘s instruct ions. The iso-
lated RNA was quant i f ied spectrophotometr ical ly at 260 nm using UV-
transparent plast ic cuvettes [Eppendorf 0300 106.300] and an Ultro-
spec III spectrophotometer [Pharmacia]. RNA content was calculated 
using the fol lowing formula: 
 
( ) factordilutionODmlgsampleRNAofionConcentrat nm ××= 26040/µ  
 
RNA samples were stored at –20°C. 
The integr i ty and puri ty of the isolated RNA were checked by denatu-
rat ing agarose gel e lectrophoresis and ethidium bromide staining. 
 
Material  
 
•  RNase-free water 
0.1% (v/v) DEPC [Sigma] in WFI. The solut ion was shaken vigorously 
to bring the DEPC into solut ion and stored at 37°C for 12 h. Then i t  
was autoclaved for 15 min at 121°C to remove any trace of DEPC. 
•  10 x FA Gel buffer 
 200 mM 3-(N-morphol ino) propanesulfonic acid (MOPS) 
 50 mM sodium acetate 
 10 mM EDTA 
adjust pH to 7.0 with 1 M NaOH 
•  1 x FA Gel Running buffer 
 100 ml 10 x FA gel buffer 
 20 ml 37% formaldehyde 
 880 ml RNase-free water 
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•  5 x RNA Loading buffer 
 16 µ l  saturated aqueous bromophenol blue solut ion 
 80 µ l  500 mM EDTA (pH 8.0) 
 720 µ l  37% formaldehyde 
 3084 µ l  formamide 
 4 ml 10 x FA gel buffer 
add RNase-free water to 10 ml. 
 
Method 
 
•  1.2% FA gel preparat ion 
 1.2 g agarose 
 10 ml 10 x FA gel buffer 
add RNase-free water to 100 ml. 
The mixture was heated in the microwave to melt the agarose. The 
solut ion was cooled down to 65°C and 1.8 ml of 37% formaldehyde 
and 1 µ l  of a 10mg/ml ethidium bromide stock solut ion was added. 
The mixture was poured onto the gel cast ing tray. 
 
•  RNA sample preparat ion 
1 volume of 5 X loading buffer was mixed with 4 volumes of RNA 
sample. The solut ion was mixed wel l ,  incubated at 65°C for 5 min 
and chi l led on ice. 
 
•  Gel running condit ions 
The gel was run at 100 V, V=const. for 1 h. 
 
Bands of separated RNA were detected using an UV lamp [Camag] at 
366 nm. 
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2.9.2 Synthesis of cDNA 
 
mRNA was specif ical ly reverse transcr ibed from total  RNA into s ingle 
stranded cDNA using an Ol igo-p(dT)15  Pr imer and the „1s t  Strand 
cDNA Synthesis Kit  for RT-PCR“ [Roche]. 
The cDNA synthesis react ions were carr ied out according to the 
manufacturer ‘s instruct ions. 
cDNA samples were stored at –20°C. 
 
 
2.9.3 Quantitative real-time TaqMan PCR 
 
To standardize the amount of cDNA added to the PCR react ion, the 
ampl i f icat ion of the mouse gene GAPDH was used as an endogenous 
control .  For ampl i f icat ion and quant itat ion of GAPDH the pr imers and 
the TaqMan  probe were designed using the software Pr imer Ex-
pressTM [Appl ied Biosystems] and the fol lowing DNA sequences: 
 
•  Mouse GAPDH (EMBL, M32599) 
•  For human GAPDH a commercial ly avai lable k i t  was used [Appl ied 
Biosystems 4310884E] 
 
For the ampl i f icat ion and quant i tat ion of tyrosinase cDNA pr imers and 
TaqMan  probe construct ion based on the fol lowing publ ished DNA 
sequence: 
 
•  Mouse tyrosinase (EMBL, M24560) 
•  Human tyrosinase (EMBL, M27160) 
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The primer nucleot ide sequences are in detai l :   
 
Mouse 
Forward pr imer 5‘-CGA CCT CTT TGT ATG GAT GCA TTA-3‘ 
Reverse pr imer 5‘-CCC AGT TAG TTC TCG AAT TTC TTG T-3‘ 
Probe 5‘-VIC-ACA TTG ATT TTG CCC ATG AAG CAC CAG-TAMRA-3‘.  
 
Human 
Forward pr imer 5‘-TCA ATG GAT GCA CTG CTT GG-3‘ 
Reverse pr imer 5‘-ACC GCA ACA AGA AGA GTC TAT GC-3‘ 
Probe 5‘-VIC-ACA TTG ATT TTG CCC ATG AAG CAC CAG-TAMRA-3‘.  
 
To ensure that the pr imers were specif ic for tyrosinase sequence, 
al ignments were performed based on the fol lowing publ ished DNA se-
quences for tyrosinase related protein 1 (TRP1) and tyrosinase re-
lated protein 2 (TRP2):  
 
Mouse 
TRP1 (EMBL, X03687) 
TRP2 (EMBL, X63349) 
 
Human 
TRP1 (EMBL, X51420) 
TRP2 (EMBL, D28767) 
 
Al l  pr imers were synthesized by Genset, France. Probes were synthe-
s ized by Appl ied Biosystems, Germany. 
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PCR condit ions were: 
 
Mouse 
 25 µ l  TaqMan Universal PCR Master Mix [Appl ied Biosystems] 
 2 µ l  Forward pr imer (8 µM) 
 2 µ l  Reverse pr imer (8 µM),  
 1 µ l  Probe (8 µM) 
 5 µ l  cDNA sample 
 15 µ l  H2O 
 
Human 
 25 µ l  TaqMan Universal PCR Master Mix [Appl ied Biosystems] 
 2 µ l  Forward pr imer (8 µM) 
 2 µ l  Reverse pr imer (8 µM),  
 1 µ l  Probe (8 µM) 
 10 µ l  cDNA sample 
 10 µ l  H2O 
 
After a hot start 45 cycles were performed as fol lows: 15 s at 95°C, 1 
min at 60°C. 
The relat ive quant i tat ion was carr ied out using the so-cal led „com-
parat ive CT method“[70]. 
Student ’s t-Test,  ANOVA and Dunnett test were used for the stat ist i -
cal  analysis of the results.  
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2.10. Influence of PUFA on melanogenesis of MelanoDerm 
 
MelanoDerm is  a pigmented skin model produced by Mattek that 
consists of normal,  human kerat inocytes and melanocytes which have 
been cultured together to form a mult i layered, highly di f ferent iated 
model of the human epidermis. The t issues are grown on cel l  culture 
inserts at the air- l iquid interface al lowing the topical  appl icat ion of 
test substances. The serum free medium contains no art i f ic ia l  st imu-
lators of melanogenesis such as TPA and IBMX. 
 
Culture of the t issues and application of test substance 
 
At the day of arr ival  the t issues were equi l ibrated and cult ivated ac-
cording to the manufacturer ’s instruct ions for 24 h. Then medium was 
changed and 25 µ l  of 1% (v/v) test substance in 10% ethanol (v/v) in 
WFI, 25 µ l  of di luent or nothing was topical ly appl ied. The t issues 
were incubated for 21 days. Every second day medium was changed 
and new test substance or di luent was appl ied.  
In the second experiment 25 µ l  of 2.5% (v/v) test substance in 25% 
ethanol or DMSO (v/v) in WFI, 25 µ l  of di luent alone or nothing was 
appl ied. The t issues were cult ivated for three weeks and every sec-
ond day medium was changed and new test substance or di luent was 
appl ied. 
At the end of the treatment the t issues were washed with PBSA and 
microscopic and macroscopic images were taken. Using the image 
analysis software Scion Image [Scion Corporat ion] the level of dark-
ening was determined. 
Melanin content in the t issues was determined by degradat ion of the 
t issues with proteinase K and extract ion of melanin according to the 
manufacturer ’s instruct ions. Data were normal ized to the control  
value and expressed as percentage of the control  ±  standard devia-
t ion. 
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3. Results 
 
3.1.Cell culture 
 
3.1.1 Normal human melanocytes 
 
When single cel l  suspensions obtained from epidermis by trypsin 
treatment were plated in the presence of PMA and IBMX, predomi-
nant ly melanocytes attached and grew. Attached and spred melanocy-
tes were c lear ly v is ib le within 24-48 h after seeding (see picture 1).  
 
 
Picture  1  Me lanocy te  p r imary  cu l tu re  48  hours  a f t e r  seed ing .  A r rows  i nd i ca te  a t t ached  
me lanocy tes .  (60x )  
 
PMA did not interfere with the growth of f ibroblasts and IBMX only 
part ia l ly supressed their growth. Replacement of IBMX with 10 nM of 
cholera toxin did neither succeed in suppressing f ibroblast growth. 
Separat ion of melanocytes from f ibroblasts by dif ferent ia l  trypsinat i-
on was successful  in many cases but i f  f ibroblast contaminat ion could 
not be stopped by this method, treatment of the cultures with the an-
t ib iot ic genet ic in select ively el iminated f ibroblasts within one week 
without k i l l ing melanocytes (see picture 2).  
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Picture  2  Me lanocy te  cu l tu re  w i th  con tam ina t i ng  f i b rob las t s  ( l e f t ) .   
The  same cu l tu re  a f t e r  t r ea tment  w i th  200  µg/m l  gene t i c i n  f o r  seven  days  ( r i gh t ) .  
 
Melanocytes showed a spindle shaped bi- or tr ipolar morphology (see 
picture 3) and a slow growth with a twofold increase in 30 days. 
 
 
Picture  3  Me lanocy te  cu l tu re  a t  passage  f i ve  (150x)  
 
Melanocytes were ident i f ied by their morphology and immuncytoche-
mistry using a specif ic monoclonal ant ibody against human tyrosina-
se. 
Human melanocytes in culture were bi- or mult ip lar dendrit ic with a 
br ight shining cel l  body.  
Stained cel ls showed a br ight f luorescence over the whole cel l  body 
(see picture 4) whi le f ibroblasts showed no f luorescence (picture not 
shown). 
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Picture  4  Immunf luo rescence  l abe l l i ng  o f  t y ros inase  i n  cu l tu red  no rma l  human me lano-
cy tes  (200x)  
 
 
3.1.2 Mouse melanoma cells 
 
B16-F1 and B16-F10 mouse melanoma cel ls showed a f ibroblast- l ike 
morphology in culture (see picture 5).   
 
 
Picture  5  Cu l tu re  o f  B16  mouse  me lanoma ce l l  l i ne  (200x)  
 
Both cel l  l ines showed a fast growth with a populat ion doubl ing t ime 
that was dependent of seeding density (see Fig.  3.1  and Tab. 3.1).   
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F ig .  3 .1  G rowth  cu rve  o f  B16-F1  and  B16-F10  mouse  me lanoma ce l l s .  ?1  x  10 4 ,  ?  3  x  
10 4 ,  ?  1  x  10 5  ce l l s /m l  
 
 
Seeding density B16-F1 B16-F10 
1 x 104 cells/ml 12 h 9 h 
3 x 104 cells/ml 14 h 12 h 
1 x 105 cells/ml 36 h 47 h 
Tab.  3 .1  Popu la t i on  doub l i ng  t imes  o f  B16  mouse  me lanoma ce l l s  a s  a  func t i on  o f  see -
d ing  dens i ty  
 
Both cel l  l ines secreted melanin to the cel l  culture medium (see pic-
ture 6),  a phenomenon that is descr ibed for B16-F1 cel ls but not for 
B16-F10. 
 
 
Picture  6  On  the  l e f t :  med ium o f  B16  mouse  me lanoma cu l tu re  th ree  days  a f t e r  see -
d ing .  On  the  r i gh t :  med ium w i thou t  ce l l s .   
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3.2 Cytotoxicity of PUFA 
 
3.2.1 Cytotoxicity on normal human melanocytes 
 
The cytotoxic i ty of the test substances was determined using the 
neutral  red assay. Cultures of normal human melanocytes were see-
ded in microt i terplates and incubated with dif ferent concentrat ions of 
polyunsaturated fatty acids in cel l  culture medium. After 72 h the vi-
able cel ls were stained with neutral  red. Cel l  v iabi l i ty in comparison 
to untreated control  was calculated and plotted against concentrat ion 
of test compound (see Fig.  3.2).  The two cel l  l ines show a s imi lar 
response to the test compounds. Al l  test substances led to a very 
smal l ,  dose-dependent reduct ion of v iabi l i ty in both cel l  l ines.  
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F ig .  3 .2  Cy to tox i c i t y  o f  l i no l e i c  a c id ,  a rach idon i c  ac id ,  α - l i no l en i c  ac id  and  γ - l i no l en i c  
ac id  on  d i f f e ren t  ce l l  l i nes  o f  cu l tu red  norma l  human  me lanocy tes  exp ressed  as  pe r cen t  
v i ab i l i t y  o f  veh i c l e  t r ea ted  con t ro l .  
?  NHMP01  passage  15 ,  ?  NHMP01  passage  22 ,  ?  NHM 11  passage  10  
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3.2.2 Cytotoxicity on mouse melanoma cells 
 
The cytotoxic i ty of the test substances was determined using the 
neutral  red assay. Cultures of B16-F1 and B16-F10 mouse melanoma 
cel ls were seeded in microt i terplates and incubated with dif ferent 
concentrat ions of polyunsaturated fatty acids in cel l  culture medium. 
After 72 h the viable cel ls were stained with neutral  red. Incorpora-
ted dye was extracted and quanti f ied with a spectrophotometer at 
540 nm. Cel l  v iabi l i ty in comparison to untreated control  was calcula-
ted and plotted against concentrat ion of test compund (see Fig 3.3).  
The two cel l  l ines showed a very s imi lar response to the test com-
pounds. Al l  test compounds led to a dose dependent reduct ion of v ia-
bi l i ty in both cel l  l ines. Incubation with 500 µM of PUFA in medium 
resulted in a complete loss of v iabi l i ty of B16 mouse melanoma cel ls.  
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F ig .  3 .3  Cy to tox i c i t y  o f  l i no l e i c  a c id ,  a rach idon i c  ac id ,  α - l i no l en i c  ac id  and  γ - l i no l en i c  
ac id  on  cu l t u res  o f  B16  mouse  me lanoma ce l l s .  Resu l t s  a re  exp ressed  as  pe rcen t  v i ab i l i -
t y  compared  to  veh i c l e  t r ea ted  con t ro l .  
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The IC50,  which is the concentrat ion of compound promoting 50% in-
hibit ion of cel l  v iabi l i ty,  was determined by curve f i t t ing using the 
software TableCurve.  The results are shown in Table 3.2 .   
 
 B16-F1 B16-F10 
Linoleic acid 273 µM 169 µM 
Arachidonic acid 184 µM 188 µM 
α-Linolenic acid 224 µM 162 µM 
γ-Linolenic acid 232 µM 162 µM 
Tab. 3.2 IC5 0  va lues  o f  the  fou r  t es ted  po l yunsa tu ra ted  fa t t y  ac ids  fo r  B16-F1  and  
B16-F10  mouse  me lanoma ce l l s . 
 
For B16-F10 cel ls the IC50 values of l inoleic acid, α- l inolenic acid and 
γ- l inolenic acid were lower than for B16-F1. There are only smal l  d i f-
ferences in cytotoxic i ty beetwen the four polyunsaturated fatty acids 
whi le the IC50 values of arachidonic acid are ident ical  for the two 
subl ines. 
In the experiments with B16-F1 cel ls l inoleic acid, α- l inolenic acid 
and γ- l inolenic acid show higher IC50 values than arachidonic acid. In 
contrast for B16-F10 cel ls the IC50 value of arachidonic acid is higher 
than the values of the remaining PUFAs. 
 
 
 Results  
 79  
3.3 Effects of PUFA on melanogenesis of mouse melanoma cells 
 
3.3.1 Tyrosinase mRNA content 
 
To elucidate the effect of PUFA on tyrosinase gene expression, the 
tyrosinase mRNA content of cel ls treated with 25 µM of test substan-
ce for 24 h was determined by real-t ime TaqMan  PCR. This method 
was chosen as i t  is a fast and sensit ive one compared with northern 
blot analys is.  As i t  is known that tumor promoting phorbol esters, 
such as PMA, can reduce tyrosinase mRNA levels in B16 mouse mela-
noma cel ls [71], we used this substance as a posit ive control for the 
assay system. Experiments showed that PMA signif icant ly reduced the 
tyrosinase mRNA level in mouse melanoma cel ls (see Fig.3.4).   
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Fig. 3.4 Reduc t i on  o f  i n t race l l u l a r  t y ros inase  mRNA con ten t  o f  B16  mouse  me lanoma  
ce l l s  a f t e r  i n cuba t i on  w i th  30  nM PMA fo r  24  hours .   
f ( c t )  co r responds  to  the  „ fo ld -exp ress ion “  re l a t i ve  to  re fe rence .  Da ta  a re  mean va lues  
o f  t r i p l i ca te  de te rm ina t i ons  ±  SD.  ANOVA and  S tuden t ’ s  t - t e s t  were  used  fo r  s ta t i s t i ca l  
ana l y s i s .  
 
In B16-F10 cel ls none of the tested PUFA had an inf luence on the ty-
rosinase mRNA level; in B16-F1 cel ls only l inoleic acid and arachi-
donic acid led to a s ignif icant (p<0.05) moderate decrease in the ty-
rosinase mRNA level (see Fig.  3.5).   
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Fig. 3.5 In f luence  o f  25  µM po l yunsa tu ra ted  f a t t y  ac id s  on  t y ros inase  mRNA con ten t  o f  
B16  mouse  me lanoma ce l l s .  Incuba t i on  t ime  was  24  h .  
f ( c t )  co r responds  to  the  „ fo ld -exp ress i on“  re l a t i ve  to  re fe rence .  Da ta  a re  mean va lues  
o f  t r i p l i ca te  de te rm ina t i ons  ±  SD.  ANOVA and  Dune t t  t e s t  were  used  fo r  s ta t i s t i c a l  ana -
l y s i s .  
 
 
3.3.2 Tyrosinase activity 
 
DOPA oxidase act iv i ty of tyrosinase in crude cel l  extracts from PUFA 
treated B16 mouse melanoma cel ls was determined using a modif ied 
vers ion of the method descr ibed by Ando [58]. In f i rst exper iments i t  
was shown that, in contrast to the results of Ando, the react ion was 
not l inear. Therefore the cel l  extract was di luted. With the di luted 
extract the react ion was l inear over a per iod of 10 min.  
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In both subl ines, B16-F1 and B16-F10, none of the tested PUFA leads 
to a decreased tyrosinase act iv i ty. Even after a 72 h incubat ion with 
test substance, the tyrosinase act iv i ty was not affected (see Fig.  
3.6).  
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Fig. 3.6 In f luence  o f  25  µM po l yunsa tu ra ted  f a t t y  ac ids  on  t y ros inase  ac t i v i t y  o f  B16  
mouse  me lanoma ce l l s  a f t e r  t r ea tment  pe r i od  o f  24 ,  48  and  72  hours .  Ty ros inase  ac t i v i -
t y  was  measu red  acco rd ing  to  a  mod i f i ed  method  o f  Ando  [58] .   
Da ta  a re  exp ressed  as  pe r cen t  o f  veh i c l e  t r ea ted  con t ro l  and  a re  mean  va lues  o f  twe l ve  
i nd i v i dua l  va lues  ±  SD .  a )  B16-F1 ;  b )  B16-F10  
 
In addit ion to the method of Ando a second assay to measure the 
DOPA oxidase act iv i ty of tyrosinase was performed. With this assay 
too, no reduct ion of tyrosinase act iv i ty of mouse melanoma cel ls  
upon treatment with PUFA could be detected (see Fig.  3.7).  
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Fig 3.7 In f l uence  o f  25  µM po l yunsa tu ra ted  f a t t y  ac ids  on  t y ros inase  ac t i v i t y  o f  B16  
mouse  me lanoma ce l l s  a f t e r  t r ea tment  pe r i od  o f  24 ,  48  and  72  h .  
Ty ros inase  ac t i v i t y  was  measu red  acco rd ing  to  a  mod i f i ed  method  o f  W inde r  [67] .   
Da ta  a re  exp ressed  as  pe r cen t  o f  veh i c l e  t r ea ted  con t ro l  and  a re  mean  va lues  o f  twe l ve  
i nd i v idua l  va lues  ±  SD . a) B16-F1; b) B16-F10 
 
 
3.3.3 Melanin content 
 
The potent ia l  of PUFA to reduce the intracel lu lar melanin content of 
B16-F1 mouse melanoma cel ls is wel l  known from the work of Ando. 
As there exist di f ferent subl ines of B16 mouse melanoma cel ls,  i t  was 
of interest to invest igate whether there are dif ferences in their res-
ponse to the treatment with PUFA.  
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Melanin from cel ls grown in the presence of PUFA for 24, 48 and 72 h 
was extracted and quanti f ied spectrophotometr ical ly.  For results see 
Fig.  3.8 .  
In both subl ines the intracel lu lar melanin content was reduced in a 
t ime-dependent manner by al l  of the tested fatty acids. α-L inolenic 
acid and γ- l inolenic acid were more potent in their effects on melanin 
content. It  was also shown that in B16-F10 cel ls,  the test substances 
led to a stronger reduct ion of the melanin content than in B16-F1 
cel ls.  
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Fig. 3.8 In f luence  o f  25  µM po l yunsa tu ra ted  f a t t y  ac ids  on  i n t race l l u l a r  me lan in  con ten t  
o f  B16  mouse  me lanoma ce l l s  a f t e r  a  t r ea tment  pe r i od  o f  24 ,  48  and  72  h .  
Da ta  a re  exp ressed  as  pe r cen t  o f  veh i c l e  t r ea ted  con t ro l  and  a re  mean  va lues  o f  twe l ve  
i nd i v idua l  va lues  ±  SD . a) B16-F1; b) B16-F10 
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In the f i rst experiments with PUFAs and mouse melanoma cel ls i t  was 
observed that medium from treated cel ls darkened much faster than 
medium from the untreated control.  To examine this effect,  secreted 
melanin in the medium and intracel lu lar pigment were measured in 
the same experiment. 
Surpr is ingly, i t  was shown that, in both subl ines, the treatment with 
25 µM of PUFA led to a s ignif icant increase of melanin in medium af-
ter 24 h (see Fig.  3.9).   
With t ime this discrepancy between untreated and treated cel ls in 
secret ion of melanin to the medium was reduced. In B1-F1 cel ls i t  oc-
curred very fast,  whi le in the B16-F10 subl ine, secret ion of melanin 
to the medium was enhanced by arachidonic and α- l inolenic acid even 
after a treatment per iod of 72 h. 
Al l  of the tested polyunsaturated fatty acids showed a t ime-
dependent inhibitory effect on intracel lu lar melanin content of B16 
mouse melanoma cel ls.  
It  is apparent that a high amount of total  melanin produced is secre-
ted to the medium. The proport ion of melanin secreted to the medi-
um is greater in cultures of B16-F1 cel ls.  In contrast B16-F1 cel ls ha-
ve a lower intracel lu lar melanin content as compared with B16-F10 
cel ls.  
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F ig .  3 .9  In t ra -  and  ex t race l l u l a r  me lan in  con ten t  o f  B16-F1  ( l e f t )  and  B16-F10  ( r i gh t )  
mouse  me lanoma ce l l s  a f t e r  t r ea tment  w i th  25  µM o f  PUFA  fo r  24 ,  48  and  72  h .  Da ta  
a re  exp ressed  as  p i cog ram me lan in  pe r  ce l l  and  a re  mean  va lues  o f  quadrup l i ca te  de -
te rm ina t i ons  ±  SD .  Dunne t  t e s t  was  used  fo r  s ta t i s t i ca l  ana l y s i s  o f  the  da ta .  
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3.3.4 Tyrosinase content 
 
Measurement of the tyrosinase content of cel ls treated with PUFA was 
performed by Western Blot and ELISA method. 
 
Western Blot 
 
Cultures of B16-F1 and B16-F10 mouse melanoma cel ls were incuba-
ted with 25 µM of PUFA for 72 h. After this incubat ion cel ls were har-
vested and proteins extracted. The protein extracts were separated 
by SDS polyacrylamide gel e lectrophoresis.  The gel was blotted on a 
PVDF membrane and tyrosinase was specif ical ly detected using a po-
lyc lonal goat ant i  mouse/rat tyrosinase ant ibody and a rabbit  anti  
goat ant ibody labeled with alkal ine phosphatase. In the f i rst exper i-
ments bands were very difuse and dif f icult to interprete. Optimizat ion 
of the transfer condit ions led to better results.  At the same t ime the 
decis ion was taken to detect the protein GAPDH on the blot.  This so-
cal led „house-keeping gene“ is often used as an endogenous loading 
control .  With these modif icat ions of  the protocol i t  was possible to 
detect a decrease in tyrosinase content in B16 mouse melanoma cel ls 
dependent on the treatment with PUFA (see picture 7).  
 
 B16-F1 B16-F10 
Tyrosinase 
 
GAPDH 
  
Picture  7  Wes te rn  b lo t  ana l y s i s  o f  t y ros inase  and  GAPDH f rom cu l tu red  B16-F1  and  
B16-F10  mouse  me lanoma ce l l s  a f t e r  t r ea tment  w i th  25  µM po l yunsa tu ra ted  fa t t y  ac ids  
fo r  72  h .  The  l anes  f rom l e f t  t o  r i gh t  i nd i ca te  the  con t ro l ,  l i no l e i c  ac id ,  a rach idon i c  a -
c id ,  α - l i no l en i c  ac id  and  γ - l i no l en i c  ac id .  
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The blots were analyzed densitometr ical ly and the results (see Fig.  
3.11) show that treatment with 25 µM of PUFA led to a reduced tyro-
s inase content that is character ized by a reduced density of tyrosina-
se bands of cel ls treated with polyunsaturated fatty acids. 
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F ig .  3 .11  Dens i tomet r i ca l  ana l y s i s  o f  wes te rn  b lo t  o f  t y ros inase  and  GAPDH o f  
B16-F1  and  B16-F10  ce l l s  t r ea ted  w i th  25  µM o f  PUFA  fo r  72  h .  Da ta  a re  exp res -
sed  as  pe rcen tage  o f  peak  a rea  o f  con t ro l .  
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ELISA 
 
With the ELISA method a s ignif icant decrease of tyrosinase content 
of mouse melanoma cel ls treated with 25 µM PUFA for 72 h, was ob-
served for al l  of the tested substances (see Fig.  3.12).  In B16-F10 
cel ls the reduct ion was not as dramatic as in B16-F1 subl ine. Dif fe-
rences beetwen the four tested fatty acids in their potent ia l  to redu-
ce tyrosinase content were not obvious. 
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Fig. 3.12 Tyros inase con tent  o f  B16-F1 and B16-F10 ce l l s  a f te r  t rea tment  w i th  25 µM PUFA fo r  
72 h  measured wi th  EL ISA.  Data  a re  expressed as  nanogramm tyros inase per  m i l l i g ramm pro-
te in  and a re  mean va lues  o f  dup l i ca te  dete rminat ions  ± SD. 
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3.4 Effects of PUFA on melanogenesis of normal human melanocytes 
 
3.4.1 Tyrosinase mRNA content 
 
As for B16 mouse melanoma cel ls,  a specif ic assay to measure the 
tyrosinase mRNA content was also developed for human melanocytes. 
Cel ls incubated with 20 µM β-estradiol  in themedium for 24 hours 
showed a s ignif icant increase in the tyrosinase mRNA content as 
measured by real-t ime TaqMan PCR. This effect of β-estradiol  on 
tyrosinase mRNA content of cultured human melanocytes is wel l  
known and was examined and publ ished by Kippenberger et a l .  [41]. 
In contrast,  the tyrosinase content of cel ls cult ivated in presence of 
100 µM PUFA for 24 h was not s ignif icant ly altered as compared with 
the untreated control  (see Fig.  3.13).  
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Fig. 3.13 In f luence  o f  20µM β -Es t rad io l  and  100  µM PUFA on  t y ros inase  mRNA con ten t  o f  
cu l tu red  human me lanocy tes .  The  t rea tment  pe r i od  was  24  h  and  da ta  a re  mean  va lues  
o f  t r i p l i ca t e  de te rm ina t i ons  ±  SD.  ANOVA and  S tuden t ’ s  t - t e s t  were  used  fo r  s ta t i s i ca l  
ana l y s i s  o f  the  da ta .  
f ( c t )  co r responds  to  the  „ fo ld -exp ress i on“  re l a t i ve  to  re fe rence .   
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3.4.2 Tyrosinase activity 
 
The four polyunsaturated fatty acids l inole ic acid, arachidonic acid, 
α- l inolenic acid and γ- l inolenic acid were tested for their abi l i ty to 
reduce tyrosinase act iv i ty in cultured human melanocytes. Test sub-
stances in ethanol as wel l  as controls were therefore appl ied to the 
medium. The cel ls were cultured in the presence of these substances 
for 72 h. DOPA oxidase act iv i ty of tyrosinase was not affected by any 
of the polyunsaturated fatty acids (see Fig.  3.14).  The experiment 
was also performed with other cel l  l ines of NHM showing very s imi lar 
results.  
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F ig .  3 .14  Ty ros inase  ac t i v i t y  o f  cu l tu red  human me lanocy tes  a f t e r  t r ea tment  w i th  100  
µM PUFA fo r  72  h .  Ty ros inase  ac t i v i t y  was  de te rm ined  acco rd ing  to  the  me thod  o f  
W inde r  [67 ] .  Da ta  a re  exp ressed  as  pe rcen tage  o f  veh i c l e  t r ea ted  con t ro l  and  a re  
mean  va lues  o f  quadrup l i ca te  de te rm ina t i ons  ±  SD.  
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3.4.3 Melanin content 
 
PUFAs were appl ied to cultures of NHM to examine their inf luence on 
the melanin content. Cel ls grown for 72 h in the presence of fatty a-
c ids were harvested and blotted on a nitrocel lu lose membrane (see 
picture 8).  The air-dr ied membrane was photographed with a digita l  
camera and the spots were analyzed densitometr ical ly (see Fig.  
3.15).  In correspondance to the results of the mRNA and tyrosinase 
act iv i ty none of the substances had an inf luence on the melanin con-
tent. These results were conf irmed by experiments with other cel l  l i -
nes of NHM. 
 
 
Picture 8 Human me lanocy tes  t r ea ted  w i th  100  µM o f  PUFA fo r  72  h  b lo t ted  on  a  n i t ro -
ce l l u l o se  membrane .  On  the  l e f t :  ce l l s  f rom the  ce l l  l i ne  NHM11 a t  passage  13 ;  on  the  
r i gh t :  the  same ce l l  l i ne  a t  passage  10 .   
C  =  con t ro l ,  V  =  veh i c l e  t r ea ted  con t ro l ,  LA  =  L ino le i c  ac id ,  AA  =  A rach idon i c  ac id ,   
α - LA  = α - L ino len i c  ac id ,  γ - LA  = γ - L ino len i c  ac i d  
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Fig. 3.15 Dens i t omet r i c  ana l y s i s  o f  b l o t t ed  human me lanocy tes  tha t  were  t rea ted  w i th  
100µM PUFA fo r  72  h .  Da ta  a re  exp ressed  as  peak  a rea  o f  the  do t s  and  a re  mean  va lues  
o f  quadrup l i ca te  de te rm ina t i ons  ±  SD.   
C V LA AA α-LA γ-LA C V LA AA α-LA γ-LA 
NHM11/13 NHM11/10 
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3.4.4 Tyrosinase content 
 
Western Blot  
 
Crude cel l  extracts from human melanocytes treated with 100 µM of 
PUFA for 72 h were separated by SDS polyacrylamide gel e lectropho-
resis and proteins were blotted on PVDF membrane. Tyrosinase and 
GAPDH (as an internal loading control) were detected with specif ic 
ant ibodies. Tyrosinase bands showed a molecular weight of about 75 
kDa and GAPDH of about 36 kDa.  
PUFAs had no effect on the tyrosinase content of human melanocy-
tes. There are dif ferences in intensity of bands of tyrosinase (see 
picture 9) but densitometr ical  analysis (Fig.  3.16) showed that inten-
sity of tyrosinase and GAPDH bands correlate very wel l ,  so the dif fe-
rences in intensity may have occured by pipett ing variat ions. 
 
Tyrosinase 
 
GAPDH 
 
Picture  9  Wes te rn  b lo t  ana l y s i s  o f  t y ros inase  and  GAPDH f rom cu l tu red  human me la -
nocy tes  a f t e r  t r ea tment  w i th  100  µM po l yunsa tu ra ted  f a t t y  ac i d s  f o r  72  h .  The  l anes  
f rom l e f t  t o  r i gh t  i nd i ca te  the  con t ro l ,  l i no l e i c  ac id ,  a rach idon i c  ac id ,  α - l i no l en i c  ac id  
and  γ - l i no l en i c  ac id .  
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F ig .  3 .16  Dens i tomet r i ca l  ana l y s i s  o f  wes te rn  b lo t  o f  t y ros inase  and  GAPDH o f  human 
me lanocy tes  t r ea ted  w i th  100  µM o f  PUFA  fo r  72  h .  Da ta  a re  exp ressed  as  pe r cen tage  
o f  peak  a rea  o f  con t ro l .  
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ELISA 
 
Alternat ively the tyrosinase content of crude cel l  extracts of human 
melanocytes treated with PUFA for 72 h was determined using ELISA 
method.  
The tyrosinase content was dramatical ly reduced by al l  of the four 
polyunsaturated fatty acids. L inoleic acid led to a reduct ion of about 
65% whi le arachidonic, α- l inolenic and γ- l inolenic acid led to a reduc-
t ion of about 30% of tyrosinase content (see Fig 3.17).  
The results of this experiment were conf irmed by an addit ional expe-
r iment that showed simi lar results.  
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Fig. 3.17 Ty ros inase  con ten t  o f  human  me lanocy tes  a f t e r  t r ea tment  w i th  100  µM PUFA  
fo r  72  h  measu red  w i th  EL ISA .  Da ta  a re  exp ressed  as  nanogramm ty ros inase  pe r  m i l l i -
g ramm pro te in  and  a re  mean  va lues  o f  dup l i ca te  de te rm ina t i ons  ±  SD.  
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3.5 Effects of PUFA on pigmentation of MelanoDerm 
 
To elucidate the quest ion i f  PUFAs have an inf luence on the pigmen-
tat ion of human melanocytes cultured in a more in vivo l ike manner, 
specimens of a pigmented reconst i tuted 3D epidermal model were 
treated with 1% (v/v) of PUFA in 10% ethanol (v/v) in WFI. After a 
treatment per iod of three weeks no l ightening of the t issues was ob-
served (see picture 10).  
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Picture  10  Me lanoDerm  t i s sues  a f t e r  a  th ree  week  t rea tment  w i th  1% o f  PUFA  in  10% 
o f  e thano l  o r  10% o f  e thano l  a l one  (veh i c l e )  o r  no  t rea tment  a t  a l l  ( con t ro l ) .  
 
The densitometr ical  analys is of the macroscopic picture of the t issues 
showed no dif ference in pigmentat ion between treated and untreated 
specimens (Fig.  3.18).  
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F ig .  3 .18  Dens i tomet r i ca l  ana l y s i s  o f  Me lanoDerm  t i s sues  t r ea ted  fo r  th ree  
weeks  w i th  1% o f  PUFA  in  10% o f  e thano l  o r  10% o f  e thano l  a l one  (veh i c l e )  o r  no  
t rea tment  a t  a l l  ( con t ro l ) .  Da ta  a re  exp ressed  as  peak  a rea  and  a re  mean  va lues  
o f  dup l i ca te  de te rm ina t i ons  ±  SD .  
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The opt ical  density of melanin extracted from the t issues was measu-
red at 405 nm (Fig.  3.20).  There was no alterat ion of the melanin 
content by treatment with PUFA. 
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F ig  3 .20  Op t i ca l  dens i t y  o f  ex t r ac ted  me lan in  f rom Me lanoDerm  t i s sues  t r ea ted  fo r  
th ree  weeks  w i th  1% o f  PUFA  in  10% o f  e thano l  o r  10% o f  e thano l  a l one  (veh i c l e )  o r  no  
r t ea tment  a t  a l l  ( con t ro l ) .  Da ta  a re  mean  va lues  o f  dup l i ca te  de te rm ina t i ons  ±  SD .  
 
In a second experiment the inf luence of a higher concentrat ion of 
PUFA on pigmentat ion of MelanoDerm t issues was examined. Speci-
mens of the 3D epidermis model were treated with 2.5% (v/v) of un-
saturated fatty acid in 25% (v/v) of ethanol or 25% (v/v) of DMSO in 
WFI for three weeks. 
After this treatment per iod no l ightening of the t issues could be ob-
served (picture 11).  Densitometr ical  analysis of the macroscopic pic-
ture of the t issues neither showed any dif ference in pigmentat ion of 
treated and untreated specimens (Fig.  3.21).  Addit ional ly spectropho-
tometr ical  analysis of extracted melanin did not show any alterat ion 
in melanin content after treatment with polyunsaturated fatty acids 
(Fig.  3.22).   
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Picture  11  Me lanoDerm  t i s sues  a f t e r  a  th ree  week  t r ea tment  w i th  2 .5% o f  PUFA  in  
veh i c l e  o r  veh i c l e  o r  no  t rea tment  a t  a l l  ( con t ro l ) .  Veh i c l e  cons i s ted  o f  25% (v /v )  o f  
e thano l  o r  25% (v /v )  o f  DMSO in  WFI .  
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F ig  3 .21  Dens i tomet r i ca l  ana l y s i s  o f  Me lanoDerm  t i s sues  t rea ted  fo r  th ree  weeks  
w i th  2 .5% o f  PUFA  o r  veh i c l e  o r  no  t rea tment  a t  a l l  ( con t ro l ) .  Veh i c l e  cons i s ted  o f  
25% (v /v )  E tOH o r  25% (v /v )  DMSO in  WFI .  Da ta  a re  exp ressed  as  peak  a rea  and  
a re  mean  va lues  o f  dup l i ca te  de te rm ina t i ons  ±  SD .  
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F ig  3 .22  Opt i ca l  dens i t y  o f  ex t ra c ted  me lan in  f rom Me lanoDerm  t i s sues  t r ea ted  fo r  
th ree  weeks  w i th  2 .5% o f  PUFA  in  veh i c l e  o r  veh i c l e  a l one  o r  no  t rea tment  a t  a l l  
( con t ro l ) .  Veh i c l e  cons i s ted  o f  25% (v /v )  o f  E tOH o r  25% (v /v )  o f  DMSO in  WFI .  Da ta  
a re  mean  va lues  o f  dup l i ca te  de te rm ina t i ons  ±  SD .  
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4. Discussion 
 
4.1 B16 mouse melanoma cells 
 
B16 mouse melanoma cel ls were chosen as an in v i tro model to inves-
t igate the inf luence of the polyunsaturated fatty acids l inoleic acid,  
arachidonic acid, α- l inolenic acid and γ- l inolenic acid on pigmenta-
t ion.  
Mouse melanoma cel ls of the B16 cel l  l ine are widely used in studies 
of the regulatory mechanisms of melanogenesis [72] because these 
cel ls have a short populat ion doubl ing t ime and produce, unl ike the 
vast major i ty of commercial ly avai lable human melanoma l ines, ample 
melanin dur ing ser ia l  passage of the cel ls.   
Var ious subl ines of this cel l  l ine exist: the European col lect ion of cel l  
cultures l ists three, the American type culture col lect ion four and the 
Riken cel l  bank f ive di f ferent subl ines. It  seems that  there are further 
subl ines that are not commercial ly avai lable. 
Reports about var iat ions between these subl ines in melanogenic ac-
t iv i ty and responsiveness to agents modulat ing melanogenesis do not 
exist.  One can speculate whether such dif ferences do not exist,  or 
whether no studies were done about this topic.  In this work i t  could 
be shown for the f i rst t ime that such var iat ions in the endogenous 
melanogenic act iv i ty and in the react ion to melanogenesis modulat ing 
compounds between B16-F1 and B16-F10 subl ine do exist.   
It  appears that the export of melanin from the cel l  is enhanced in the 
B16-F1 subl ine compared to the B16-F10 subl ine. Under normal cul-
ture condit ions B16-F1 cel ls secrete 80 to 95% of the melanin pro-
duced to the medium, whi le for B16-F10 cel ls the amount of secreted 
melanin ranges from 60 to 90%. With increasing cult ivat ion t ime the 
secreted melanin accumulates in the medium and therefore the 
amount of extracel lu lar melanin increases too.  
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Cultures of B16-F1 subl ine show twentyfour hours after seeding an 
increase of extracel lu lar melanin from 50 pg/cel l  compared to 285 
pg/cel l  after a culture t ime of seventytwo hours, whi le the intracel lu-
lar melanin content is quite stable and var ies only from 13 to 21 
pg/cel l .   
In contrast the intracel lu lar melanin content of B16-F10 cel ls is 
s l ightly higher and var ies from 19 to 24 pg/cel l ,  whi le the content of 
extracel lu lar melanin increases from 30 pg/cel l  to 253 pg/cel l  over a 
culture per iod of seventytwo hours.  
Very l i t t le is known about the factors that control  the secret ion of 
melanin in B16 mouse melanoma cel ls.  It  was shown that in cultures 
of B16/C3 cel ls serum is required to induce the secret ion of melanin 
to the medium [73]. If  these cel ls were grown in a serum-free, hor-
mone-supplemented medium, melanin was produced after induct ion of 
melanogenesis with MSH or dibutyryl  cAMP, but was not secreted to 
the medium. It was speculated that a serum factor that is non dialyz-
able and can be part ia l ly pur i f ied by Sephadex chromatography is re-
sponsible for the regulat ion of melanin secret ion. Surpr is ingly this 
factor was not further character ized. Other factors that may play a 
role in the regulat ion of melanin secret ion to the extracel lu lar space 
are calc ium [74] and citrate [66].  
The results from our work show that the polyunsaturated fatty acids 
l inoleic acid, arachidonic acid, α- l inolenic acid and γ- l inolenic acid 
are capable of increasing the secret ion of melanin to the medium. 
Addit ional ly to this st imulat ion of melanin secret ion the intracel lu lar 
melanin content is decreased by the polyunsaturated fatty acids. 
From the data obtained i t  is obvious that dependent on the subl ine 
the tested polyunsaturated fatty acids exhibit  di f ferences in the po-
tency of reduct ion of intracel lu lar melanin content. In cel ls of the 
B16-F10 subl ine the inf luence of fatty acids is more potent on in-
tracel lu lar ly stored melanin compared to the B16-F1 subl ine.  
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In contrast to the results of Ando [58] the inhibit ion of melanogene-
sis by PUFAs is not correlated with the number of unsaturated bonds, 
as arachidonic acid that has four unsaturated bonds inhibited 
melanogenesis in an equal ly effect ive manner as l inoleic acid that 
contains only two double bonds.  
In both subl ines the unsaturated fatty acids that contain three double 
bonds, α- l inolenic acid and γ- l inolenic acid, inhibited melanogenesis 
most effect ively. One may be surpr ised that although arachidonic acid 
contains the largest number of unsaturated bonds among the fatty 
acids tested, i t  does not show the most inhibitory effect on melano-
genesis.  This was expected from the results of a study where the 
pharmocological  effect of l inoleic acid was reversed by adding the 
ant ioxidant v i tamin E and which suggested that unsaturated bonds 
correlate with the inhibitory effect on melanogenesis [75]. 
However, saturated fatty acids, such as palmit ic acid and stear ic 
acid, accelerate melanogenesis [57], suggest ing that unsaturated 
bonds are not the only factor that affect melanogenesis of murine 
cel ls in v i tro. In organ-cultured guinea pig skin, arachidonic acid 
shows a total ly di f ferent act ion as i t  st imulates melanogenesis [76]. 
However, this induct ion of melanogenesis is caused by an increase in 
tyrosinase-posit ive melanocytes and not by an increase in melanin 
product ion of the s ingle melanocyte. This increase of tyrosinase-
posit ive melanocytes may be caused by a st imulat ion of melanocyte 
prol i ferat ion as i t  is known that the arachidonic acid metabol i tes leu-
kotr iene C4 and D4 are capable of st imulat ing melanocyte prol i fera-
t ion in vitro [77]. 
One can speculate that between the st imulat ion of melanin transport 
to the extracel lu lar space and the reduct ion of intracel lu lar ly stored 
pigment, a causal connect ion exists and that the enhanced secret ion 
of melanin is caused by a change in membrane f lu idity mediated by 
the polyunsaturated fatty acids.  
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Today i t  is known that diets def ic ient in l inoleic acid, or that compri-
se unusual rat ios of l inole ic acid to α- l inolenic acid induce changes in 
the PUFA composit ion of neuronal and gl ia l  membranes and lead to 
modif icat ions in membrane f lu idity,  in the act iv i t ies of membrane-
associated, funct ional proteins (transporters, receptors, enzymes), 
and in the product ion of important s ignal ing molecules from oxygena-
ted l inole ic and α- l inolenic acid der ivat ives [78, 79]. Whether such 
modif icat ions may also occur in mouse melanoma cel ls and i f  they 
can modulate the secret ion of melanin to the medium is not known. 
Our results suggest that the decrease in intracel lu lar melanin content 
of B16 mouse melanoma cel ls upon incubation with PUFA is not medi-
ated by the accelerat ion of melanin secret ion because i)  there is a 
delay between the increase in secret ion and the decrease in intracel-
lu lar melanin content and i i )  the surplus of melanin secreted upon 
treatment with PUFA is much larger than the reduct ion of the intra-
cel lu lar melanin content. Therefore i t  seems that the accelerat ion of 
melanin secret ion and the reduct ion of intracel lu lar melanin content 
are two dist inct effects.  
As stated before, an explanat ion for the increase in extracel lu lar me-
lanin content can be alterat ions in membrane integr i ty leading to an 
exaggerated secret ion of melanin. In this case the overal l  product ion 
of melanin must be enhanced too, as the intracel lu lar melanin con-
tent is not decreased at the same t ime.  
One may also speculate that the darkening of the medium upon 
treatment with PUFA is not caused by the secret ion of melanin produ-
ced intracel lu lar ly but by the extracel lu lar product ion of dopachrome 
from tyrosine abundant in the medium. This extracel lu lar product ion 
of pigment must be catalyzed by tyrosinase.  
From our work we know that addit ion of mushroom tyrosinase to cul-
ture medium leads to a rapid darkening of the solut ion (unpubl ished 
results).  It  is not known i f  tyrosinase or ig inated from B16 mouse me-
lanoma cel ls and released to the medium causes the same effect.   
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The inf luence of polyunsaturated fatty acids on the intracel lu lar 
melanin content of B16 mouse melanoma cel ls is a much more com-
plex story and the mechanisms behind this inhibit ion of melanogene-
sis are speculat ive as some results from our work are in contrast to 
the results of Ando and co-workers.  
Contrary to Ando and co-workers [59] we were not able to detect an 
inhibitory effect of polyunsaturated fatty acids on tyrosinase act iv i ty. 
Surpr ised by these f indings we ver i f ied our results by repet ing the 
experiments several  t imes and using two dif ferent assays for measur-
ing the dopa oxidase act iv i ty of tyrosinase with the result  that no re-
duct ion of the act iv i ty of the enzyme could be detected. 
In accordance to Ando [61] results from our western blott ing and 
ELISA experiments show that tyrosinase protein levels of B16 mouse 
melanoma cel ls were decreased by the polyunsaturated fatty acids 
after a seventytwo hour incubation. These f indings do not correlate 
with our results from the tyrosinase act iv i ty assays. Possible explana-
t ions for this potent ia l  contradict ion in our results are:  
1.  The ant ibody used for detect ion of tyrosinase does not bind to 
al l  isoforms of tyrosinase [80, 81] and therefore detects only a 
proport ion of the overal l  tyrosinase present in the cel ls.  
2.  The tyrosinase content of cel ls treated with polyunsaturated 
fatty acids is lowered but the catalyt ic act iv i ty of the enzyme is 
increased. 
3.  The two explanat ions above may explain why there is a reduc-
t ion in tyrosinase content without affect ion of tyrosinase act iv-
i ty.  It  is not yet c lear why intracel lu lar melanin should be re-
duced when there is no reduct ion in tyrosinase act iv i ty.  It  can 
be speculated that this reduct ion may be caused by a disorder 
of the complex of tyrosinase, TRP1, TRP2 and s i lverprotein [82] 
located in the melanosome membrane by an alterat ion in the 
membrane f lu idity of the organel le. 
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4.  Another explanat ion may be that the assays for measuring the 
act iv i ty of tyrosinase are not specif ic for tyrosinase and there-
fore the results for tyrosinase act iv i ty are false. In our opinion 
i t  seems to be unl ikely that two dif ferent assays del iver fa lse 
results at the same t ime. The assays are wel l  establ ished and 
are often used in studies on melanogenesis.  
Al l  of the hypotheses l isted above are speculat ive and further work 
wi l l  perhaps enl ighten the contradict ion of our results.  
It  has been reported that l inoleic acid at concentrat ions consistent 
with those for the inhibit ion of melanogenesis in B16-F10 cel ls does 
not alter the cel l  tyrosinase mRNA levels [60]. For B16-F10 cel ls the 
results from our TaqMan RT-PCR experiments are in accordance 
with these f indings. For B16-F1 cel ls our results c learly show a s ig-
nif icant reduct ion of tyrosinase mRNA levels by treatment with l i -
noleic acid and arachidonic acid. The tyrosinase mRNA levels of the 
cel ls are also reduced after treatment with α- l inolenic acid and γ-
l inolenic acid but the reduct ion is not s ignif icant when the results are 
stat ist ical ly analyzed with the Dunnet test.  If  Student ’s t-test is used 
for stat ist ical  analysis of the results,  the reduct ion of tyrosinase 
mRNA level is s ignif icant for l inoleic acid, arachidonic acid and γ-
l inolenic acid but the results for α- l inolenic acid are not s ignif icant. 
Nevertheless i t  seems that the reduct ion in tyrosinase protein levels 
in B16-F1 cel ls is regulated at the transcr ipt ional level ,  whi le in B16-
F10 cel ls  the reduct ion of tyrosinase content is caused by modif ica-
t ions at the translat ional or post-translat ional level .  
Ando and co-workers suggest,  that the reduct ion of tyrosinase pro-
tein levels in B16-F10 cel ls after treatment with the polyunsaturated 
fatty acid l inoleic acid is caused by an accelerat ion of the proteolyt ic 
degradation of the enzyme. The exact mechanism of this proteolyt ic 
degradation remains unclear. It is speculated that in normal human 
melanocytes some tyrosinase is normal ly degraded by proteasomes 
and that in amelanot ic melanoma cel l  l ines, tyrosinase fai led to reach 
the melanosome because i t  was retained in the endoplasmatic ret icu-
 Discussion  
 104  
lum and then degraded [83]. It  is not known if  under normal culture 
condit ions tyrosinase in B16 murine melanoma cel ls is degraded by 
proteasomes. 
 
 
4.2 Normal human melanocytes 
 
Interest ingly no work was done to invest igate the effect of polyun-
saturated fatty acids on melanogenesis of human melanocytes in v i tro 
or in v ivo, although there exists a patent on conjugated l inoleic acid 
and/or der ivat ives thereof suitable as a cosmetic ingredient for skin 
l ightening. The act iv i ty of this ingredient was proven by a pigmenta-
t ion assay using B16-F1 murine melanoma cel ls.  Incubat ion with con-
jugated l inoleic acid for 72 h led to a dramatic reduct ion in secreted 
melanin. It  is not known i f  the intracel lu lar melanin content was al-
tered too.  
We have chosen two in v i tro systems to elucidate the effect of the 
polyunsaturated fatty acids l inoleic acid, arachidonic acid, α- l inolenic 
acid and γ- l inolenic acid on pigmentat ion of human melanocytes.  
Normal human melanocytes isolated from foreskins and cultured in 
medium containing serum and the two potent synergyst ic mitogens 
for melanocyte growth IBMX and PMA [84] served as a f i rst in v i tro 
system. In this system we invest igated the inf luence of 100 µM of the 
polyunsaturated fatty acids mentioned above on tyrosinase mRNA 
level ,  tyrosinase protein content,  tyrosinase act iv i ty and amount of 
intracel lu lar melanin of cultured human melanocytes. With one excep-
t ion, our results show that none of the substances affects the 
melanogenesis of human melanocytes.  
Measuring the tyrosinase protein level of PUFA treated cel ls with our 
ELISA assay we found a decrease in enzyme level compared to the 
untreated control .  I f  the tyrosinase content was invest igated with the 
Western blot method no variat ion in tyrosinase content between 
treated and untreated cel ls could be detected.  
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We are convinced that the polyunsaturated fatty acids do not affect 
the tyrosinase protein level of human melanocytes in v i tro. The re-
sults of the ELISA assay have to be interpreted with care as the cel ls 
used for the assay suffered from toxic effects of the test substances. 
It  was obvious that with increasing passage number human melano-
cytes became more suscept ible to unsaturated fatty acids. These cy-
totoxic effects were a big problem in our ELISA experiments with 
polyunsaturated fatty acids and human melanocytes. It  was tr ied to 
redo the ELISA experiments and to reproduce our f indings with other 
cel l  l ines of human melanocytes with the result  that among the cel ls  
incubated with 100 µM of polyunsaturated fatty acids, a lmost al l  d ied 
within twentyfour hours. After some further attempts the experiments 
had to be stopped, because i t  was impossible to obtain a suff ic iently 
high amount of cel l  mater ia l .  Due to the low sensit iv i ty of the ELISA, 
about 3 x 107 cel ls had to be used for a s ingle exper iment.  
It  is not known yet, why there are such dif ferences in the cytotoxic 
potentia l  of the four polyunsaturated fatty acids on dif ferent cel l  
l ines of human melanocytes.  
As a monolayer culture of human melanocytes where the cel ls are 
forced to prol i ferate by the addit ion of the tumor promoting agent 
PMA and IBMX that increases the intracel lu lar cAMP level ,  to the me-
dium does not resemble the in v ivo s i tuat ion, we have chosen a 
commercial ly avai lable reconst i tuted pigmented epidermis to further 
invest igate the inf luence of polyunsaturated fatty acids on human 
melanogenesis.   
We decided to use Mattek’s MelanoDermT M system that consists of 
normal,  human-der ived epidermal kerat inocytes (NHEK) and melano-
cytes (NHM) which have been cultured to form a mult i layered, highly 
di f ferentiated model of human epidermis that exhibits in v ivo- l ike 
morphological  and ultrastructural  character ist ics which are uniform 
and highly reproducible. The NHM within co-cultures undergo sponta-
neous melanogenesis leading to t issues of varying levels of pigmenta-
t ion.  
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The t issues are produced using serum free medium without art i f ic ia l  
st imulators of melanogenesis such as TPA and IBMX. The cultures are 
grown on cel l  culture inserts at the air- l iquid interface, a l lowing for 
topical appl icat ion of skin l ighteners or sel f-tanning agents. Thus, the 
model provides a useful  in v i tro means to evaluate cosmetic and 
pharmaceut ical  agents designed [85]. 
We tested var ious concentrat ions of the polyunsaturated fatty acids 
l inoleic acid, arachidonic acid, α- l inolenic acid and γ- l inolenic acid in 
the MelanoDerm system using ethanol and DMSO as vehic le for ap-
pl icat ion. Our results show that none of the substances has an in-
f luence on pigmentat ion of the MelanoDerm t issues. 
Taking together the results from the MelanoDerm system and the 
monolayer system it  is obvious that the polyunsaturated fatty acids 
tested do not affect melanogenesis of human melanocytes in v i tro. 
These results suggest that polyunsaturated fatty acids do not in-
f luence human pigmentat ion in v ivo. 
 
 
4.3 Concluding remarks 
 
The def in i t ive funct ions of polyunsaturated fatty acids on melano-
genesis st i l l  remain unclear. In this work we could demonstrate that 
l inole ic acid, arachidonic acid, α- l inolenic acid and γ- l inolenic acid do 
affect the biosynthesis of melanin pigment of murine melanoma cel ls 
in v i tro, whereas in human melanocytes in v i tro they show no obvious 
effect on pigmentat ion.  
In the murine model system the polyunsaturated fatty acids seem to 
have two dist inct effects on melanogenesis: the accelerat ion of se-
cret ion of intracel lu lar ly produced melanin to the extracel lu lar space 
and the reduct ion of intracel lu lar melanin content.  
In our opinion these effects are not direct ly correlated. To prove this 
hypothesis,  the fol lowing experimental approaches are possible: 
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1.  Measuring the potent ia l  of polyunsaturated fatty acids to cause 
secret ion of intracel lu lar ly produced melanin to the extracel lu lar 
space in a cel l  culture system consist ing of B16 mouse mela-
noma cel ls and culture condit ions where melanin is not secreted 
to the surrounding culture f lu id. These studies are possible 
when B16 cel ls are cultured in a serum free medium and 
melanogenesis is induced with either melanocyte-st imulat ing 
hormone or dibutyryl  cAMP. Another interest ing quest ion is,  i f  
the intracel lu lar melanin content of B16 cel ls cultured under 
such condit ions is reduced by treatment with polyunsaturated 
fatty acids. 
 
2.  Detect ion of extracel lu lar tyrosinase act iv i ty and  enzyme level 
of cultures of B16 mouse melanoma cel ls under normal condi-
t ions and after treatment with polyunsaturated fatty acids. This 
wi l l  e lucidate the quest ion whether darkening of medium is,  at 
least part ia l ly,  caused by product ion of dopachrome from tyro-
s ine abundant in the medium. 
 
Although our results show that polyunsaturated fatty acids have no 
inf luence on melanogenesis of human melanocytes in v i tro the hy-
pothesis that polyunsaturated fatty acids do not affect human pig-
mentat ion has to be proven by an in vivo study. 
It  remains unclear why polyunsaturated fatty acids affect the pigmen-
tat ion of murine melanoma cel ls but not that of human melanocytes. 
The main conclusion from our work is the fact that melanin modulat-
ing agents di f fer in their act ions on melanogenesis when tested in 
di f ferent in v i tro cel l  culture models.   
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